Oaktree Strategic Income II 10-Q 2020 Q1 Quarterly report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
	OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
	OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 000-55975

OaktreeStrategic Income II, Inc.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

DELAWARE (State or jurisdiction of incorporation or organization)	83-0566439 (I.R.S. Employer Identification No.)
333 South Grand Avenue, 28th Floor Los Angeles, CA (Address of principal executive office)	90071 (Zip Code)

REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE:

(213) 830-6300

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods as the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  x     NO  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    YES  ¨   NO  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o	Accelerated filer  o	Non-accelerated filer  x	Smaller reporting company  o
Emerging growth company  x	If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act)    YES  ¨     NO  x

Securities registered pursuant to Section 12(b) of the Act

Title of Each Class	Trading Symbol(s)	Name of Exchange on Which Registered
N/A	N/A	N/A

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at May 11, 2020
Common stock, $0.001 par value	17,407,857

OAKTREE STRATEGIC INCOME II, INC.

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2020

TABLE OF CONTENTS

		PART I — FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements:
		Consolidated Statements of Assets and Liabilities as of March 31, 2020 (unaudited) and September 30, 2019	1
		Consolidated Statements of Operations (unaudited) for the three and six months ended March 31, 2020 and 2019	2
		Consolidated Statements of Changes in Net Assets (unaudited) for the three and six months ended March 31, 2020 and 2019	3
		Consolidated Statements of Cash Flows (unaudited) for the six months ended March 31, 2020 and 2019	4
		Consolidated Schedule of Investments as of March 31, 2020 (unaudited)	5
		Consolidated Schedule of Investments as of September 30, 2019	14
		Notes to Consolidated Financial Statements (unaudited)	20
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations		44
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		58
Item 4.	Controls and Procedures		60
		PART II — OTHER INFORMATION
Item 1.	Legal Proceedings		60
Item 1A.	Risk Factors		60
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		61
Item 3.	Defaults Upon Senior Securities		61
Item 4.	Mine Safety Disclosures		61
Item 5.	Other Information		62
Item 6.	Exhibits		63
Signatures			64

PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements.

Oaktree Strategic Income II, Inc.

Consolidated Statements of Assets and Liabilities

	March 31, 2020 (unaudited)			September 30, 2019
ASSETS
Assets:
Investments – Non-control/Non-affiliate, at fair value (cost March 31, 2020: $390,195,496; cost September 30, 2019: $289,322,834)	$	354,696,821		$	291,147,011
Cash and cash equivalents	32,558,185			11,079,015
Restricted cash	2,247,126			269,111
Interest receivable	1,044,637			1,005,398
Receivables from unsettled transactions	4,345,100			5,326,435
Derivative assets at fair value	55,258			77,558
Deferred financing costs	986,630			1,314,732
Receivable for shares sold	2,412,000			347,500
Other assets	362,799			382,727
Total assets	$	398,708,556		$	310,949,487
LIABILITIES AND NET ASSETS
Liabilities:
Accounts payable, accrued expenses and other liabilities	$	755,972		$	999,579
Base management fee and incentive fee payable	1,670,324			1,128,658
Due to affiliates	295,582			753,665
Interest payable	1,270,551			1,065,903
Payables from unsettled transactions	43,696,890			52,374,932
Deferred tax liability	5,555			—
Credit facilities payable	150,000,000			83,000,000
Total liabilities	197,694,874			139,322,737
Commitments and contingencies (Note 11)
Net assets:
Common stock, $0.001 par value per share, 250,000,000 shares authorized; 11,575,664 shares issued and outstanding at March 31, 2020; 8,309,861 shares issued and outstanding at September 30, 2019	11,576			8,310
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized; none issued and outstanding at March 31, 2020 and September 30, 2019	—			—
Additional paid-in-capital	236,352,706			168,819,173
Accumulated distributable earnings (loss)	(35,350,600		)	2,799,267
Total net assets (equivalent to $17.37 and $20.65 per common share at March 31, 2020 and September 30, 2019, respectively) (Note 10)	201,013,682			171,626,750
Total liabilities and net assets	$	398,708,556		$	310,949,487

See notes to Consolidated Financial Statements.

1

Oaktree Strategic Income II, Inc.

Consolidated Statements of Operations

(unaudited)

	Three months ended March 31, 2020			Three months ended March 31, 2019			Six months ended March 31, 2020			Six months ended March 31, 2019
Interest income:
Non-control/Non-affiliate investments	$	6,292,982		$	1,942,044		$	11,276,999		$	2,761,263
Interest on cash and cash equivalents	21,586			56,782			50,968			80,271
Total interest income	6,314,568			1,998,826			11,327,967			2,841,534
PIK interest income:
Non-control/Non-affiliate investments	374,393			191,748			525,625			259,694
Total PIK interest income	374,393			191,748			525,625			259,694
Fee income:
Non-control/Non-affiliate investments	447,367			9,114			577,314			264,678
Total fee income	447,367			9,114			577,314			264,678
Total investment income	7,136,328			2,199,688			12,430,906			3,365,906
Expenses:
Base management fee	866,511			332,290			1,652,645			453,219
Investment income incentive fee	803,813			—			853,728			—
Capital gains incentive fee	(1,104,890		)	350,369			(427,572		)	308,348
Offering costs	—			194,104			—			362,373
Organization expenses	—			710			—			56,921
Professional fees	253,793			190,929			421,776			383,769
Directors fees	38,750			26,250			77,637			52,500
Interest expense	1,631,976			453,272			2,987,169			587,155
Administrator expense	130,370			130,052			244,287			212,097
General and administrative expenses	195,863			225,569			404,009			369,501
Total expenses	2,816,186			1,903,545			6,213,679			2,785,883
Net investment income before taxes	4,320,142			296,143			6,217,227			580,023
Excise tax expense	—			—			—			9,357
Net investment income	4,320,142			296,143			6,217,227			570,666
Unrealized appreciation (depreciation):
Non-control/Non-affiliate investments	(40,448,299		)	2,437,869			(37,326,082		)	1,440,249
Foreign currency forward contracts	37,386			(25,295		)	(22,300		)	9,240
Net unrealized appreciation (depreciation)	(40,410,913		)	2,412,574			(37,348,382		)	1,449,489
Realized gains (losses):
Non-control/Non-affiliate investments	266,897			(523		)	590,954			8,946
Foreign currency forward contracts	40,961			83,308			40,961			83,308
Net realized gains (losses)	307,858			82,785			631,915			92,254
Provision for income tax (expense) benefit	(309		)	—			(5,555		)	—
Net realized and unrealized gains (losses), net of taxes	(40,103,364		)	2,495,359			(36,722,022		)	1,541,743
Net increase (decrease) in net assets resulting from operations	$	(35,783,222	)	$	2,791,502		$	(30,504,795	)	$	2,112,409
Net investment income (loss) per common share — basic and diluted	$	0.51		$	0.09		$	0.74		$	0.19
Earnings (loss) per common share — basic and diluted (Note 5)	$	(4.22	)	$	0.82		$	(3.63	)	$	0.70
Weighted average common shares outstanding — basic and diluted	8,489,301			3,391,900			8,399,091			3,033,543

See notes to Consolidated Financial Statements.

2

Oaktree Strategic Income II, Inc.

Consolidated Statements of Changes in Net Assets

(unaudited)

	Three months ended March 31, 2020			Three months ended March 31, 2019		Six months ended March 31, 2020			Six months ended March 31, 2019
Operations:
Net investment income	$	4,320,142		$	296,143	$	6,217,227		$	570,666
Net unrealized appreciation (depreciation)	(40,410,913		)	2,412,574		(37,348,382		)	1,449,489
Net realized gains (losses)	307,858			82,785		631,915			92,254
Provision for income tax (expense) benefit	(309		)	—		(5,555		)	—
Net increase (decrease) in net assets resulting from operations	(35,783,222		)	2,791,502		(30,504,795		)	2,112,409
Capital share transactions:
Distributions to stockholders	(2,576,058		)	—		(7,645,072		)	—
Issuance of common stock	67,536,799			—		67,536,799			36,702,030
Net increase (decrease) in net assets from capital share transactions	64,960,741			—		59,891,727			36,702,030
Total increase (decrease) in net assets	29,177,519			2,791,502		29,386,932			38,814,439
Net assets at beginning of period	171,836,163			66,395,254		171,626,750			30,372,317
Net assets at end of period	$	201,013,682		$	69,186,756	$	201,013,682		$	69,186,756
Net asset value per common share	$	17.37		$	20.40	$	17.37		$	20.40
Common shares outstanding at end of period	11,575,664			3,391,900		11,575,664			3,391,900

See notes to Consolidated Financial Statements.

3

Oaktree Strategic Income II, Inc.

Consolidated Statements of Cash Flows

(unaudited)

	Six months ended March 31, 2020			Six months ended March 31, 2019
Operating activities:
Net increase (decrease) in net assets resulting from operations	$	(30,504,795	)	$	2,112,409
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net unrealized (appreciation) depreciation	37,348,382			(1,449,489		)
Net realized (gains) losses	(631,915		)	(92,254		)
PIK interest income	(525,625		)	(259,694		)
Accretion of original issue discount on investments	(1,119,252		)	(275,394		)
Amortization of deferred financing costs	330,347			120,581
Amortization of deferred offering costs	—			362,373
Deferred taxes	5,555			—
Purchases of investments	(188,883,931		)	(141,509,006		)
Proceeds from sales and repayments of investments	90,284,784			5,677,327
Changes in operating assets and liabilities:
(Increase) decrease in interest receivable	(39,239		)	(429,798		)
(Increase) decrease in receivables from unsettled transactions	981,335			—
(Increase) decrease in other assets	19,928			22,225
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(243,607		)	172,466
Increase (decrease) in base management fee and incentive fee payable	541,666			600,915
Increase (decrease) in due to affiliates	(458,083		)	(546,342		)
Increase (decrease) in interest payable	204,648			387,846
Increase (decrease) in payables from unsettled transactions	(8,678,042		)	20,014,338
Net cash used in operating activities	(101,367,844		)	(115,091,497		)
Financing activities:
Distributions paid in cash	(7,645,072		)	—
Borrowings under the credit facilities	130,000,000			76,000,000
Repayments of borrowings under the credit facilities	(63,000,000		)	—
Proceeds from the issuance of common stock	65,472,299			36,742,030
Deferred financing costs paid	(2,245		)	(530,405		)
Offering costs paid	—			(120,992		)
Net cash provided by financing activities	124,824,982			112,090,633
Effect of exchange rate changes on foreign currency	47			45,289
Net increase (decrease) in cash and cash equivalents and restricted cash	23,457,185			(2,955,575		)
Cash and cash equivalents and restricted cash, beginning of period	11,348,126			10,131,268
Cash and cash equivalents and restricted cash, end of period	$	34,805,311		$	7,175,693
Supplemental information:
Cash paid for interest	$	2,452,174		$	78,728
Non-cash financing activities:
Proceeds from the issuance of common stock	$	2,412,000		$	—
Reconciliation to the Consolidated Statement of Assets and Liabilities	March 31, 2020			September 30, 2019
Cash and cash equivalents	$	32,558,185		$	11,079,015
Restricted cash	2,247,126			269,111
Total cash and cash equivalents and restricted cash	$	34,805,311		$	11,348,126

See notes to Consolidated Financial Statements.

4

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
Non-Control/Non-Affiliate Investments												(6)
Access CIG, LLC			Diversified Support Services
First Lien Term Loan, LIBOR+3.75% cash due 2/27/2025	5.53	%		$	7,513,107	$	7,451,988		$	6,188,922		(4)
						7,451,988			6,188,922
Accupac, Inc.			Personal Products
First Lien Term Loan, LIBOR+6.00% cash due 1/17/2026	7.84	%		4,582,336		4,504,889			4,502,145			(4)(7)(11)
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 1/17/2026				—		(14,476		)	(14,989		)	(4)(7)(8)
First Lien Revolver, LIBOR+6.00% cash due 1/17/2026	7.05	%		571,008		561,357			561,015			(4)(7)
						5,051,770			5,048,171
Acquia Inc.			Application Software
First Lien Term Loan, LIBOR+7.00% cash due 10/31/2025	8.58	%		4,381,994		4,300,289			4,175,164			(4)(7)
First Lien Revolver, LIBOR+7.00% cash due 10/31/2025				—		(8,967		)	(22,118		)	(4)(7)(8)
						4,291,322			4,153,046
Adient US LLC			Auto Parts & Equipment
First Lien Term Loan, LIBOR+4.00% cash due 5/6/2024	5.45	%		4,962,500		4,937,688			4,391,813			(4)(9)
						4,937,688			4,391,813
AI Sirona (Luxembourg) Acquisition S.a.r.l.			Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 9/28/2026	7.25	%		€	2,500,000	2,862,090			2,139,638			(4)(7)(9)
						2,862,090			2,139,638
Aldevron, L.L.C.			Biotechnology
First Lien Term Loan, LIBOR+4.25% cash due 10/12/2026	5.70	%		$	4,000,000	3,960,000			3,780,000			(4)(11)
						3,960,000			3,780,000
Algeco Scotsman Global Finance Plc			Construction & Engineering
Fixed Rate Bond, 8.00% cash due 2/15/2023				566,000		575,947			437,218			(9)
						575,947			437,218
Altice France S.A.			Integrated Telecommunication Services
First Lien Term Loan, LIBOR+4.00% cash due 8/14/2026	4.70	%		6,887,000		6,517,765			6,594,303			(4)(9)(11)
						6,517,765			6,594,303
Alvogen Pharma US, Inc.			Pharmaceuticals
First Lien Term Loan, LIBOR+5.25% cash due 12/31/2023	6.32	%		2,646,943		2,322,132			2,302,840			(4)(7)(11)
						2,322,132			2,302,840
Alvotech Holdings S.A.			Biotechnology
Fixed Rate Bond 15% PIK Note A due 12/13/2023				2,000,000		2,369,936			2,487,521			(7)(9)(10)
Fixed Rate Bond 15% PIK Note B due 12/13/2023				2,000,000		2,369,936			2,429,671			(7)(9)(10)
						4,739,872			4,917,192
Anastasia Parent, LLC			Personal Products
First Lien Term Loan, LIBOR+3.75% cash due 8/11/2025	5.20	%		1,851,913		1,543,024			1,080,480			(4)
						1,543,024			1,080,480
Apptio, Inc.			Application Software
First Lien Term Loan, LIBOR+7.25% cash due 1/10/2025	8.25	%		7,129,297		7,014,046			6,794,219			(4)(7)
First Lien Revolver, LIBOR+7.25% cash due 1/10/2025				—		(7,348		)	(21,692		)	(4)(7)(8)
						7,006,698			6,772,527
Assembled Brands Capital LLC			Specialized Finance
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 10/17/2023	6.99	%		824,928		824,928			661,707			(4)(7)(8)
174,131 Class A Units						82,713			99,255			(7)
100,285 Preferred Units, 6%						110,285			113,593			(7)
7,621 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029						—			—			(7)
						1,017,926			874,555

5

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost		Fair Value		Notes
Associated Asphalt Partners, LLC			Construction Materials
First Lien Term Loan, LIBOR+5.25% cash due 4/5/2024	6.25	%		$	926,739	$	762,243	$	671,886	(4)
						762,243		671,886
Asurion, LLC			Property & Casualty Insurance
First Lien Term Loan, LIBOR+3.00% cash due 11/3/2024	3.99	%		261,335		234,548		252,188		(4)(11)
Second Lien Term Loan, LIBOR+6.50% cash due 8/4/2025	7.49	%		1,141,000		1,143,698		1,057,564		(4)(11)
						1,378,246		1,309,752
Atlas Senior Loan Fund XV, Ltd.			Multi-Sector Holdings
Class E Notes, LIBOR+7.54% cash due 10/23/2032	9.46	%		268,000		171,275		169,285		(4)(9)
						171,275		169,285
Aurora Lux Finco S.À.R.L.			Airport Services
First Lien Term Loan, LIBOR+6.00% cash due 12/24/2026	7.00	%		7,500,000		7,319,759		7,051,125		(4)(7)(9)
						7,319,759		7,051,125
Avoca Capital CLO X Designated Activity Company			Multi-Sector Holdings
Class ER Notes, EURIBOR+6.05% cash due 1/15/2030	6.05	%		€	268,000	199,607		226,793		(4)(9)
						199,607		226,793
Ball Metalpack Finco, LLC			Metal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 7/31/2025	6.11	%		$	1,473,750	1,468,088		1,136,261		(4)(7)(11)
						1,468,088		1,136,261
BCP Renaissance Parent L.L.C.			Oil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+3.50% cash due 10/31/2024	4.95	%		429,174		406,106		235,330		(4)(11)
						406,106		235,330
Boxer Parent Company Inc.			Systems Software
First Lien Term Loan, LIBOR+4.25% cash due 10/2/2025	5.24	%		8,530,178		8,372,830		7,172,813		(4)
						8,372,830		7,172,813
Buckeye Partners, L.P.			Oil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+2.75% cash due 11/1/2026	4.27	%		1,380,988		1,229,079		1,278,105		(4)
						1,229,079		1,278,105
Cadence Aerospace, LLC			Aerospace & Defense
First Lien Term Loan, LIBOR+6.50% cash due 11/14/2023	8.28	%		2,999,215		2,969,222		2,840,601		(4)(7)
						2,969,222		2,840,601
Canyon Buyer, Inc.			Application Software
First Lien Term Loan, LIBOR+4.25% cash due 2/15/2025	5.71	%		3,949,622		3,910,488		3,554,660		(4)
						3,910,488		3,554,660
Carlyle US CLO 2019-3, Ltd.			Multi-Sector Holdings
Class D Notes, LIBOR+7.03% cash due 10/20/2032	9.11	%		182,000		113,590		123,716		(4)(9)
						113,590		123,716
CGG Holding (U.S.) Inc.			Oil & Gas Equipment & Services
Fixed Rate Bond, 9.00% cash due 5/1/2023				352,700		364,100		298,384		(9)
						364,100		298,384
Chief Power Finance II, LLC			Independent Power Producers & Energy Traders
First Lien Term Loan, LIBOR+6.50% cash due 12/31/2022	7.95	%		8,287,500		8,107,555		7,816,770		(4)(7)
						8,107,555		7,816,770
CITGO Petroleum Corp.			Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+5.00% cash due 3/28/2024	6.00	%		7,920,000		7,840,800		7,009,200		(4)(11)
						7,840,800		7,009,200
Commscope, Inc.			Communications Equipment
First Lien Term Loan, LIBOR+3.25% cash due 4/6/2026	4.24	%		2,491,739		2,370,459		2,367,152		(4)(9)(11)
						2,370,459		2,367,152

6

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
Connect U.S. Finco LLC			Alternative Carriers
First Lien Term Loan, LIBOR+4.50% cash due 12/11/2026	5.49	%		$	9,941,000	$	9,696,389		$	8,014,931		(4)(9)(11)
						9,696,389			8,014,931
Continental Intermodal Group LP			Oil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+8.50% PIK due 1/28/2025				11,375,321		11,375,321			10,635,925			(4)(7)(11)(12)
						11,375,321			10,635,925
Convergeone Holdings, Inc.			IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/2026	5.99	%		5,878,610		5,679,277			4,629,405			(4)
						5,679,277			4,629,405
Corrona, LLC			Health Care Services
First Lien Term Loan, LIBOR+5.75% cash due 12/13/2025	6.75	%		3,779,703		3,716,878			3,666,312			(4)(7)(11)
First Lien Delayed Draw Term Loan, LIBOR+5.75% cash due 12/13/2025				—		(11,699		)	(40,110		)	(4)(7)(8)(11)
First Lien Revolver, PRIME + 4.75% cash due 12/13/2025	8.00	%		446,000		434,880			425,930			(4)(7)(8)
401 Class A2 Common Units in Corrona Group Holdings, L.P.						401,000			401,000			(7)
						4,541,059			4,453,132
CPI Holdco, LLC			Health Care Supplies
First Lien Term Loan, LIBOR+4.25% cash due 11/4/2026	5.70	%		5,803,000		5,778,000			5,106,640			(4)(11)
						5,778,000			5,106,640
Crown Point CLO 7 Ltd.			Multi-Sector Holdings
Class E Notes, LIBOR+6.30% cash due 10/20/2031	8.12	%		989,000		709,581			562,539			(4)(9)
						709,581			562,539
CTOS, LLC			Trading Companies & Distributors
First Lien Term Loan, LIBOR+4.25% cash due 4/18/2025	5.00	%		2,954,620		2,973,132			2,548,360			(4)(11)
						2,973,132			2,548,360
Cypress Intermediate Holdings III, Inc.			Application Software
First Lien Term Loan, LIBOR+2.75% cash due 4/29/2024	3.75	%		855,800		748,825			790,695			(4)
						748,825			790,695
Dcert Buyer, Inc.			Internet Services & Infrastructure
First Lien Term Loan, LIBOR+4.00% cash due 10/16/2026	4.99	%		8,000,000		7,980,000			7,193,360			(4)(11)
						7,980,000			7,193,360
Dealer Tire, LLC			Distributors
First Lien Term Loan, LIBOR+4.25% cash due 12/12/2025	5.24	%		8,509,498		8,415,294			7,077,052			(4)(11)
						8,415,294			7,077,052
Delta 2 (Lux) S.à.r.l.			Movies & Entertainment
First Lien Term Loan, LIBOR+2.50% cash due 2/1/2024	3.50	%		809,000		688,150			730,414			(4)(9)(11)
						688,150			730,414
The Dun & Bradstreet Corporation			Research & Consulting Services
First Lien Term Loan, LIBOR+4.00% cash due 2/6/2026	4.96	%		2,500,000		2,508,632			2,271,875			(4)(11)
						2,508,632			2,271,875
EHR Canada, LLC			Food Retail
First Lien Term Loan, LIBOR+8.00% cash due 9/28/2020	9.45	%		457,407		455,270			460,608			(4)(7)
						455,270			460,608
Elevation CLO 2013-1, Ltd.			Multi-Sector Holdings
Class D1R2 Notes, LIBOR+7.65% cash due 8/15/2032	9.34	%		512,000		395,520			342,669			(4)(9)
						395,520			342,669
Elevation CLO 2018-9, Ltd.			Multi-Sector Holdings
Class E Notes, LIBOR+6.30% cash due 7/15/2031	8.13	%		460,000		285,704			271,112			(4)(9)
						285,704			271,112

7

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
Elevation CLO 2018-10, Ltd.			Multi-Sector Holdings
Class E Notes, LIBOR+6.29% cash due 10/20/2031	8.12	%		$	509,000	$	385,584		$	294,473		(4)(9)
						385,584			294,473
Ellie Mae, Inc.			Application Software
First Lien Term Loan, LIBOR+3.75% cash due 4/17/2026	5.20	%		5,970,000		5,925,225			5,246,138			(4)(11)
						5,925,225			5,246,138
eResearch Technology, Inc.			Application Software
First Lien Term Loan, LIBOR+4.50% cash due 2/4/2027	5.95	%		4,000,000		3,960,000			3,548,000			(4)(11)
						3,960,000			3,548,000
Frontier Communications Corporation			Integrated Telecommunication Services
First Lien Term Loan, LIBOR+3.75% cash due 6/15/2024	5.21	%		7,714,737		7,604,148			7,373,591			(4)(9)(11)
Fixed Rate Bond, 8.50% cash due 4/1/2026				2,216,000		2,109,971			2,037,501
						9,714,119			9,411,092
GFL Environmental, Inc.			Environmental & Facilities Services
First Lien Term Loan, LIBOR+3.00% cash due 5/30/2025	4.00	%		861,000		794,519			839,118			(4)(9)(11)
						794,519			839,118
GI Chill Acquisition LLC			Managed Health Care
First Lien Term Loan, LIBOR+4.00% cash due 8/6/2025	5.45	%		1,970,000		1,960,150			1,704,050			(4)(7)
Second Lien Term Loan, LIBOR+7.50% cash due 8/6/2026	8.95	%		2,000,000		1,984,091			1,740,000			(4)(7)
						3,944,241			3,444,050
Global Medical Response			Health Care Services
First Lien Term Loan, LIBOR+4.25% cash due 3/14/2025	5.86	%		1,084,360		1,064,246			978,635			(4)
						1,064,246			978,635
GoodRx, Inc.			Interactive Media & Services
First Lien Term Loan, LIBOR+2.75% cash due 10/10/2025	3.74	%		1,023,380		882,541			967,094			(4)(11)
						882,541			967,094
Guidehouse LLP			Research & Consulting Services
First Lien Term Loan, LIBOR+4.50% cash due 5/1/2025	5.49	%		4,477,215		4,434,425			3,671,316			(4)(11)
						4,434,425			3,671,316
Helios Software Holdings, Inc.			Systems Software
First Lien Term Loan, LIBOR+4.25% cash due 10/24/2025	5.32	%		2,992,500		2,962,575			2,578,533			(4)(11)
						2,962,575			2,578,533
HNC Holdings, Inc.			Building Products
First Lien Term Loan, LIBOR+4.00% cash due 10/5/2023	5.00	%		625,712		584,660			566,269			(4)
						584,660			566,269
Hyland Software, Inc.			Systems Software
First Lien Term Loan, LIBOR+3.25% cash due 7/1/2024	4.24	%		301,235		269,857			282,785			(4)
						269,857			282,785
iCIMs, Inc.			Application Software
First Lien Term Loan, LIBOR+6.50% cash due 9/12/2024	7.50	%		1,671,765		1,646,418			1,602,386			(4)(7)
First Lien Revolver, LIBOR+6.50% cash due 9/12/2024				—		(1,670		)	(3,662		)	(4)(7)(8)
						1,644,748			1,598,724
Intelsat Jackson Holdings S.A.			Alternative Carriers
First Lien Term Loan, LIBOR+3.75% cash due 11/27/2023	5.68	%		2,953,778		2,859,164			2,737,783			(4)(9)(11)
First Lien Term Loan, LIBOR+4.50% cash due 1/2/2024	6.43	%		246,000		222,630			229,272			(4)(9)
						3,081,794			2,967,055
Intrawest Resorts Holdings, Inc.			Leisure Facilities
First Lien Term Loan, LIBOR+2.75% cash due 7/31/2024	3.74	%		342,125		292,517			313,044			(4)(11)
						292,517			313,044
KIK Custom Products Inc.			Household Products
First Lien Term Loan, LIBOR+4.00% cash due 5/15/2023	5.00	%		2,000,000		1,922,892			1,809,170			(4)(9)
						1,922,892			1,809,170

8

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
Level 3 Financing, Inc.			Alternative Carriers
First Lien Term Loan, LIBOR+1.75% cash due 3/1/2027	2.74	%		$	2,254,000	$	2,034,235		$	2,125,804		(4)(9)
						2,034,235			2,125,804
Lightbox Intermediate, L.P.			Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/2026	5.80	%		8,932,500		8,814,976			7,815,938			(4)(7)
						8,814,976			7,815,938
LTI Holdings, Inc.			Auto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/2026	7.74	%		1,000,000		1,000,000			542,000			(4)
						1,000,000			542,000
Maravai Intermediate Holdings, LLC			Biotechnology
First Lien Term Loan, LIBOR+4.25% cash due 8/1/2025	5.75	%		1,280,500		1,267,695			1,120,438			(4)(7)
						1,267,695			1,120,438
McAfee, LLC			Systems Software
First Lien Term Loan, LIBOR+3.75% cash due 9/30/2024	4.69	%		490,754		436,771			463,763			(4)
						436,771			463,763
Mindbody, Inc.			Internet Services & Infrastructure
First Lien Term Loan, LIBOR+7.00% cash due 2/14/2025	8.00	%		7,238,095		7,120,489			6,695,238			(4)(7)
First Lien Revolver, LIBOR+7.00% cash due 2/14/2025	8.07	%		761,905		749,525			704,762			(4)(7)
						7,870,014			7,400,000
Mountain View CLO XIV Ltd.			Multi-Sector Holdings
Class E Notes, LIBOR+6.71% cash due 4/15/2029	8.54	%		214,000		131,952			146,772			(4)(9)
						131,952			146,772
MRI Software LLC			Application Software
First Lien Term Loan, LIBOR+5.50% cash due 2/10/2026	6.57	%		4,641,397		4,597,033			4,107,636			(4)(7)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026				—		(4,844		)	(92,617		)	(4)(7)(8)
First Lien Revolver, LIBOR+5.50% cash due 2/10/2026	6.57	%		230,596		225,984			177,559			(4)(7)(8)
						4,818,173			4,192,578
Navicure, Inc.			Health Care Technology
First Lien Term Loan, LIBOR+4.00% cash due 10/22/2026	4.99	%		7,628,000		7,291,463			7,074,970			(4)(11)
						7,291,463			7,074,970
OEConnection LLC			Application Software
First Lien Term Loan, LIBOR+4.00% cash due 9/25/2026	5.45	%		8,634,102		8,590,931			6,972,037			(4)(11)
First Lien Delayed Draw Term Loan, LIBOR+4.00% cash due 9/25/2026				—		(3,959		)	(158,333		)	(4)(8)(11)
						8,586,972			6,813,704
Olaplex, Inc.			Personal Products
First Lien Term Loan, LIBOR+6.50% cash due 1/8/2026	7.50	%		9,500,000		9,317,281			8,882,500			(4)(7)(11)
First Lien Revolver, LIBOR+6.50% cash due 1/8/2025	7.50	%		1,026,000		1,006,423			959,310			(4)(7)
						10,323,704			9,841,810
OZLM Funding III, Ltd.			Multi-Sector Holdings
Class DR Notes, LIBOR+7.77% cash due 1/22/2029	9.58	%		1,630,000		1,212,322			937,250			(4)(9)
						1,212,322			937,250
P & L Development, LLC			Pharmaceuticals
First Lien Term Loan, LIBOR+7.50% cash due 6/28/2024	9.50	%		4,089,450		4,001,811			3,578,269			(4)(7)
						4,001,811			3,578,269
PaySimple, Inc.			Data Processing & Outsourced Services
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 8/23/2025	6.48	%		1,816,385		1,764,927			1,574,011			(4)(7)(8)(11)
First Lien Term Loan, LIBOR+5.50% cash due 8/23/2025	6.46	%		8,263,475		8,113,989			7,519,762			(4)(7)(11)
						9,878,916			9,093,773

9

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost		Fair Value		Notes
Petsmart, Inc.			Specialty Stores
First Lien Term Loan, LIBOR+4.00% cash due 3/11/2022	5.00	%		$	588,000	$	529,200	$	565,438	(4)(11)
						529,200		565,438
ProFrac Services, LLC			Industrial Machinery
First Lien Term Loan, LIBOR+6.25% cash due 9/15/2023	8.14	%		1,325,833		1,316,645		1,160,104		(4)(7)(11)
						1,316,645		1,160,104
Project Boost Purchaser, LLC			Application Software
Second Lien Term Loan, LIBOR+8.00% cash due 5/9/2027	8.99	%		1,500,000		1,500,000		1,162,500		(4)(7)
						1,500,000		1,162,500
Quikrete Holdings, Inc.			Construction Materials
First Lien Term Loan, LIBOR+2.50% cash due 2/1/2027	3.49	%		3,088,260		2,852,780		2,856,641		(4)(11)
						2,852,780		2,856,641
Recorded Books Inc.			Publishing
First Lien Term Loan, LIBOR+4.25% cash due 8/29/2025	4.95	%		7,847,084		7,808,970		6,944,669		(4)(11)
						7,808,970		6,944,669
Rockies Express Pipeline LLC			Oil & Gas Storage & Transportation
Fixed Rate Bond, 6.88% cash due 4/15/2040				1,359,000		883,056		822,278
						883,056		822,278
Sabert Corporation			Metal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 12/10/2026	5.50	%		4,350,000		4,306,500		4,045,500		(4)(11)
						4,306,500		4,045,500
Scientific Games International, Inc.			Casinos & Gaming
First Lien Term Loan, LIBOR+2.75% cash due 8/14/2024	3.74	%		353,099		284,245		286,598		(4)(9)(11)
						284,245		286,598
Scilex Pharmaceuticals Inc.			Pharmaceuticals
Fixed Rate Zero Coupon Bond due 8/15/2026				2,357,448		1,740,251		1,709,150		(7)
						1,740,251		1,709,150
Shackleton 2018-XII CLO, Ltd.			Multi-Sector Holdings
Class E Notes, LIBOR+5.90% cash due 7/20/2031	7.72	%		521,000		370,944		297,650		(4)(9)
						370,944		297,650
Shackleton 2019-XIV CLO, Ltd.			Multi-Sector Holdings
Class D Notes, LIBOR+6.48% cash due 7/20/2030	8.30	%		396,000		240,228		208,890		(4)(9)
						240,228		208,890
Signify Health, LLC			Health Care Services
First Lien Term Loan, LIBOR+4.50% cash due 12/23/2024	5.95	%		6,929,293		6,870,747		5,820,606		(4)(11)
						6,870,747		5,820,606
Sirva Worldwide, Inc.			Diversified Support Services
First Lien Term Loan, LIBOR+5.50% cash due 8/4/2025	6.49	%		1,937,500		1,908,438		1,453,125		(4)
						1,908,438		1,453,125
Sorrento Therapeutics, Inc.			Biotechnology
First Lien Term Loan, LIBOR+7.00% cash due 11/7/2023	8.50	%		5,157,195		4,858,041		5,083,543		(4)(7)(9)
503,119 Common Stock Warrants (exercise price $3.28) expiration date 5/7/2029						560,000		442,745		(7)(9)
106,664 Common Stock Warrants (exercise price $3.94) expiration date 11/3/2029						—		89,598		(7)(9)
160,000 Common Stock Warrants (exercise price $3.26) expiration date 6/6/2030						—		132,800		(7)(9)
						5,418,041		5,748,686
Star US Bidco LLC			Industrial Machinery
First Lien Term Loan, LIBOR+4.25% cash due 3/17/2027	5.94	%		4,024,000		3,983,760		3,500,880		(4)(11)
						3,983,760		3,500,880

10

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost		Fair Value		Notes
Sunshine Luxembourg VII SARL			Personal Products
First Lien Term Loan, LIBOR+4.25% cash due 10/1/2026	5.32	%		$	6,394,973	$	6,246,881	$	5,819,425	(4)(9)
						6,246,881		5,819,425
Supermoose Borrower, LLC			Application Software
First Lien Term Loan, LIBOR+3.75% cash due 8/29/2025	5.20	%		1,792,017		1,668,660		1,444,365		(4)
						1,668,660		1,444,365
Surgery Center Holdings, Inc.			Health Care Facilities
First Lien Term Loan, LIBOR+3.25% cash due 9/2/2024	4.25	%		331,760		254,317		257,280		(4)(9)
						254,317		257,280
Tacala, LLC			Restaurants
Second Lien Term Loan, LIBOR+7.50% cash due 2/4/2028	8.49	%		2,247,000		2,241,439		1,758,278		(4)
						2,241,439		1,758,278
Thunder Finco (US), LLC			Movies & Entertainment
First Lien Term Loan, LIBOR+4.25% cash due 11/26/2026	5.24	%		6,000,000		5,940,000		4,695,000		(4)(7)(9)(11)
						5,940,000		4,695,000
TIBCO Software Inc.			Application Software
First Lien Term Loan, LIBOR+3.75% cash due 6/30/2026	4.74	%		9,437,270		9,447,771		8,965,406		(4)(11)
Second Lien Term Loan, LIBOR+7.25% cash due 3/3/2028	8.24	%		3,278,000		3,261,610		3,130,490		(4)
						12,709,381		12,095,896
Transact Holdings Inc.			Application Software
First Lien Term Loan, LIBOR+4.75% cash due 4/30/2026	5.74	%		7,960,000		7,840,600		6,169,000		(4)(7)
						7,840,600		6,169,000
Turbocombustor Technology, Inc.			Aerospace & Defense
First Lien Term Loan, LIBOR+4.50% cash due 12/2/2020	5.50	%		1,258,622		1,132,378		1,107,587		(4)(11)
						1,132,378		1,107,587
Uber Technologies, Inc.			Application Software
First Lien Term Loan, LIBOR+3.50% cash due 7/13/2023	4.49	%		3,948,849		3,935,994		3,731,662		(4)
First Lien Term Loan, LIBOR+4.00% cash due 4/4/2025	5.00	%		1,902,740		1,850,508		1,790,155		(4)(9)(11)
						5,786,502		5,521,817
UFC Holdings, LLC			Movies & Entertainment
First Lien Term Loan, LIBOR+3.25% cash due 4/29/2026	4.25	%		439,860		387,077		392,026		(4)(11)
						387,077		392,026
Uniti Fiber Holdings Inc.			Specialized REITs
Fixed Rate Bond, 7.88% cash due 2/15/2025				6,889,000		6,889,000		6,458,438		(9)
Fixed Rate Bond, 8.25% cash due 10/15/2023				1,814,000		1,724,792		1,410,385		(9)
						8,613,792		7,868,823
U.S. Renal Care, Inc.			Health Care Services
First Lien Term Loan, LIBOR+5.00% cash due 6/26/2026	6.00	%		406,977		333,722		359,886		(4)(11)
						333,722		359,886
Veritas US Inc.			Application Software
First Lien Term Loan, LIBOR+4.50% cash due 1/27/2023	5.95	%		4,293,021		4,111,083		3,718,830		(4)(11)
						4,111,083		3,718,830
Verscend Holding Corp.			Health Care Technology
First Lien Term Loan, LIBOR+4.50% cash due 8/27/2025	5.49	%		9,172,331		9,154,196		8,713,714		(4)(11)
						9,154,196		8,713,714
WeddingWire, Inc.			Interactive Media & Services
First Lien Term Loan, LIBOR+4.50% cash due 12/19/2025	5.95	%		2,962,500		2,950,280		2,592,188		(4)(11)
						2,950,280		2,592,188

11

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
WideOpenWest Finance, LLC			Cable & Satellite
First Lien Term Loan, LIBOR+3.25% cash due 8/18/2023	4.25	%		$	1,223,862	$	1,104,782		$	1,141,251		(4)(9)(11)
						1,104,782			1,141,251
WP CPP Holdings, LLC			Aerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/2025	5.53	%		3,950,750		3,928,521			3,012,445			(4)(11)
						3,928,521			3,012,445
WPEngine, Inc.			Application Software
First Lien Term Loan, LIBOR+6.50% cash due 3/27/2026	7.77	%		5,118,050		4,990,391			4,990,099			(4)(7)
First Lien Delayed Draw Term Loan, LIBOR+6.50% cash due 3/27/2026				—		(237,081		)	(237,624		)	(4)(7)(8)
						4,753,310			4,752,475
Total Non-Control/Non-Affiliate Investments (176.5% of net assets)						$	390,195,496		$	354,696,821
Cash and Cash Equivalents and Restricted Cash (17.3% of net assets)						$	34,805,311		$	34,805,311
Total Portfolio Investments, Cash and Cash Equivalents and Restricted Cash (193.8% of net assets)						$	425,000,807		$	389,502,132

Derivative Instrument	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Counterparty	Cumulative Unrealized Appreciation (Depreciation)
Foreign currency forward contract	$	2,981,267	€	2,662,178	5/14/2020	Bank of New York Mellon	$	55,258

(1) All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.

(2) See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.

(3) Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

(4) The interest rate on the principal balance outstanding for all floating rate loans is indexed to the London Interbank Offered Rate ("LIBOR") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate based rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of March 31, 2020, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 0.99%, the 60-day LIBOR at 1.26%, the 90-day LIBOR at 1.45%, the 180-day LIBOR at 1.07%, the PRIME at 3.25% and the 30-day Euro Interbank Offered Rate ("EURIBOR") at (0.40)%. Most loans include an interest floor, which generally ranges from 0% to 1%.

(5) "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

(6) Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities and/or has the power to exercise control over the management or policies of the company. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

(7) As of March 31, 2020, these investments are categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820") and were valued using significant unobservable inputs.

(8) Investment has undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

(9) Investment is not a qualifying asset as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of March 31, 2020, qualifying assets represented 79.1% of the Company's total assets and non-qualifying assets represented 20.9% of the Company's total assets.

(10) Payment-in-kind ("PIK") interest income for this investment accrues at an annualized rate of 15%, however, the PIK interest is not contractually capitalized on the investment. As a result, the principal amount of the investment does not increase over time for accumulated PIK interest. As of March 31, 2020, the accumulated PIK interest balance for each of the Alvotech A notes and the B notes was $0.4 million. The fair value of this investment is inclusive of PIK.

12

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

March 31, 2020

(unaudited)

(11) All or a portion of this investment is pledged as collateral under the Citibank Facility (as defined in Note 6 to the accompanying notes to the Consolidated Financial Statements).

(12) During the quarter ended March 31, 2020, this portfolio company modified its scheduled interest payment to PIK.

See notes to Consolidated Financial Statements.

13

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

September 30, 2019

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
Non-Control/Non-Affiliate Investments												(6)
Access CIG, LLC			Diversified Support Services
First Lien Term Loan, LIBOR+3.75% cash due 2/27/2025	6.07	%		$	7,551,410	$	7,483,710		$	7,471,214		(4)
						7,483,710			7,471,214
Adient US LLC			Auto Parts & Equipment
First Lien Term Loan, LIBOR+4.25% cash due 5/6/2024	6.46	%		4,987,500		4,962,563			4,918,922			(4)(9)
						4,962,563			4,918,922
AI Sirona (Luxembourg) Acquisition S.a.r.l.			Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 7/10/2026	7.25	%		€	2,500,000	2,862,090			2,667,597			(4)(9)
						2,862,090			2,667,597
Air Medical Group Holdings, Inc.			Health Care Services
First Lien Term Loan, LIBOR+4.25% cash due 3/14/2025	6.29	%		$	1,089,907	1,067,643			1,023,602			(4)
						1,067,643			1,023,602
Aldevron, L.L.C.			Biotechnology
First Lien Term Loan, LIBOR+4.25% cash due 9/20/2026	6.36	%		4,000,000		3,960,000			4,020,000			(4)(11)
						3,960,000			4,020,000
Algeco Scotsman Global Finance Plc			Construction & Engineering
Fixed Rate Bond, 8.00% cash due 2/15/2023				1,000,000		1,020,274			1,002,800			(9)
						1,020,274			1,002,800
Altice France S.A.			Integrated Telecommunication Services
First Lien Term Loan, LIBOR+4.00% cash due 8/14/2026	6.03	%		4,000,000		4,000,000			3,997,500			(4)(9)
						4,000,000			3,997,500
Alvotech Holdings S.A.			Biotechnology
Fixed Rate Bond, 15.00% PIK Note A due 12/13/2023				2,000,000		2,203,231			2,444,400			(7)(9)(10)
Fixed Rate Bond, 15.00% PIK Note B due 12/13/2023				2,000,000		2,203,231			2,244,400			(7)(9)(10)
						4,406,462			4,688,800
Apptio, Inc.			Application Software
First Lien Term Loan, LIBOR+7.25% cash due 1/10/2025	9.56	%		7,129,297		7,001,960			6,997,404			(4)(7)
First Lien Revolver, LIBOR+7.25% cash due 1/10/2025				—		(8,119		)	(8,538		)	(4)(7)(8)
						6,993,841			6,988,866
Assembled Brands Capital LLC			Specialized Finance
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 10/17/2023	8.10	%		—		604,359			604,359			(4)(7)(8)
174,131 Class A Units						82,713			84,576			(7)
110,285 Preferred Units, 6%						110,285			110,285			(7)
7,621 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029						—			—			(7)
						797,357			799,220
Avantor Inc.			Health Care Distributors
Fixed Rate Bond, 9.00% cash due 10/1/2025				1,000,000		1,015,805			1,126,250
						1,015,805			1,126,250
Ball Metalpack Finco, LLC			Metal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 7/31/2025	6.62	%		1,481,250		1,475,024			1,397,930			(4)(7)(11)
						1,475,024			1,397,930
Boxer Parent Company Inc.			Systems Software
First Lien Term Loan, LIBOR+4.25% cash due 10/2/2025	6.29	%		8,573,368		8,404,544			8,265,456			(4)
						8,404,544			8,265,456
Canyon Buyer, Inc.			Application Software
First Lien Term Loan, LIBOR+4.25% cash due 2/15/2025	6.36	%		3,969,773		3,926,398			3,949,924			(4)
						3,926,398			3,949,924

14

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

September 30, 2019

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost		Fair Value		Notes
Cast & Crew Payroll, LLC			Application Software
First Lien Term Loan, LIBOR+4.00% cash due 2/9/2026	6.05	%		$	3,980,000	$	3,940,200	$	4,014,825	(4)
						3,940,200		4,014,825
CGG Holding (U.S.) Inc.			Oil & Gas Equipment & Services
Fixed Rate Bond, 9.00% cash due 5/1/2023				819,000		849,160		876,330		(9)
						849,160		876,330
Cincinnati Bell Inc.			Integrated Telecommunication Services
29,443 Common Equity Shares						129,979		149,276
First Lien Term Loan, LIBOR+3.25% cash due 10/2/2024	5.29	%		4,987,406		4,944,677		4,982,543		(4)(11)
						5,074,656		5,131,819
CITGO Petroleum Corp.			Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+5.00% cash due 3/28/2024	7.10	%		7,960,000		7,880,400		8,009,750		(4)(11)
						7,880,400		8,009,750
Connect U.S. Finco LLC			Alternative Carriers
First Lien Term Loan, LIBOR+4.50% cash due 9/23/2026	7.10	%		9,500,000		9,310,000		9,367,143		(4)(9)(11)
						9,310,000		9,367,143
Convergeone Holdings, Inc.			IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/2026	7.04	%		5,908,300		5,690,535		5,341,103		(4)
						5,690,535		5,341,103
Dcert Buyer, Inc.			Internet Services & Infrastructure
First Lien Term Loan, LIBOR+4.00% cash due 8/8/2026	6.26	%		8,000,000		7,980,000		7,985,000		(4)(11)
						7,980,000		7,985,000
DigiCert, Inc.			Internet Services & Infrastructure
First Lien Term Loan, LIBOR+4.00% cash due 10/31/2024	6.04	%		3,922,038		3,887,944		3,921,214		(4)
						3,887,944		3,921,214
DKT Finance APS			Integrated Telecommunication Services
Fixed Rate Bond, 9.38% cash due 6/17/2023				207,000		215,982		223,250		(9)
						215,982		223,250
The Dun & Bradstreet Corporation			Research & Consulting Services
First Lien Term Loan, LIBOR+5.00% cash due 2/6/2026	7.05	%		2,500,000		2,509,371		2,518,525		(4)(11)
Fixed Rate Bond, 6.88% cash due 8/15/2026				5,000,000		5,000,000		5,459,375
						7,509,371		7,977,900
EHR Canada, LLC			Food Retail
First Lien Term Loan, LIBOR+8.00% cash due 9/28/2020	10.10	%		974,073		964,897		993,555		(4)(7)
						964,897		993,555
ExGen Renewables IV, LLC			Electric Utilities
First Lien Term Loan, LIBOR+3.00% cash due 11/28/2024	5.13	%		1,251,000		1,202,830		1,227,156		(4)
						1,202,830		1,227,156
Femur Buyer, Inc.			Health Care Equipment
First Lien Term Loan, LIBOR+4.25% cash due 3/5/2026	6.38	%		4,987,500		4,937,625		4,996,851		(4)
						4,937,625		4,996,851
Financial & Risk US Holdings, Inc.			Financial Exchanges & Data
First Lien Term Loan, LIBOR+3.75% cash due 10/1/2025	5.79	%		5,637,116		5,591,298		5,673,531		(4)(11)
						5,591,298		5,673,531

15

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

September 30, 2019

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
Frontier Communications Corporation			Integrated Telecommunication Services
First Lien Term Loan, LIBOR+3.75% cash due 6/15/2024	5.80	%		$	6,772,891	$	6,691,179		$	6,770,487		(4)(9)(11)
Fixed Rate Bond, 8.50% cash due 4/1/2026				2,035,000		1,980,283			2,039,884
						8,671,462			8,810,371
Gentiva Health Services, Inc.			Health Care Services
First Lien Term Loan, LIBOR+3.75% cash due 7/2/2025	5.81	%		2,992,443		2,988,796			3,013,016			(4)(11)
						2,988,796			3,013,016
GI Chill Acquisition LLC			Managed Health Care
First Lien Term Loan, LIBOR+4.00% cash due 8/6/2025	6.10	%		1,980,000		1,970,100			1,975,050			(4)(7)
Second Lien Term Loan, LIBOR+7.50% cash due 8/6/2026	9.60	%		2,000,000		1,982,835			2,000,000			(4)(7)
						3,952,935			3,975,050
GoodRx, Inc.			Interactive Media & Services
First Lien Term Loan, LIBOR+2.75% cash due 10/10/2025	4.81	%		1,962,982		1,960,647			1,965,435			(4)
Second Lien Term Loan, LIBOR+7.50% cash due 10/12/2026	9.54	%		1,333,333		1,308,330			1,350,000			(4)(7)
						3,268,977			3,315,435
HUB International Limited			Insurance Brokers
First Lien Term Loan, LIBOR+3.00% cash due 4/25/2025	5.27	%		3,969,849		3,903,391			3,930,369			(4)
						3,903,391			3,930,369
iCIMs, Inc.			Application Software
First Lien Revolver, LIBOR+6.50% cash due 09/12/2024				—		(1,456		)	(1,478		)	(4)(7)(8)
First Lien Term Loan, LIBOR+6.50% cash due 9/12/2024	8.56	%		1,671,765		1,643,564			1,643,761			(4)(7)
						1,642,108			1,642,283
Informatica, LLC			Application Software
First Lien Term Loan, LIBOR+3.25% cash due 8/5/2022	5.29	%		3,969,612		3,955,083			3,990,293			(4)
						3,955,083			3,990,293
KIK Custom Products Inc.			Household Products
First Lien Term Loan, LIBOR+4.00% cash due 5/15/2023	6.26	%		2,000,000		1,910,503			1,902,500			(4)(9)
						1,910,503			1,902,500
Ligand Pharmaceuticals Inc.			Biotechnology
Fixed Rate Bond, 0.75% cash due 5/15/2023				1,001,000		884,224			836,788			(9)
						884,224			836,788
Lightbox Intermediate, L.P.			Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/2026	7.05	%		8,977,500		8,849,687			8,887,725			(4)(7)
						8,849,687			8,887,725
LTI Holdings, Inc.			Auto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/2026	8.79	%		1,000,000		1,000,000			916,250			(4)
						1,000,000			916,250
Maravai Intermediate Holdings, LLC			Biotechnology
First Lien Term Loan, LIBOR+4.25% cash due 8/2/2025	6.31	%		1,287,000		1,274,130			1,279,761			(4)(7)
						1,274,130			1,279,761
McAfee, LLC			Systems Software
First Lien Term Loan, LIBOR+3.75% cash due 9/30/2024	5.79	%		4,844,529		4,833,441			4,861,315			(4)
						4,833,441			4,861,315
Mindbody, Inc.			Internet Services & Infrastructure
First Lien Revolver, LIBOR+7.00% cash due 2/15/2025				—		(13,652		)	(14,476		)	(4)(7)(8)
First Lien Term Loan, LIBOR+7.00% cash due 2/14/2025	9.06	%		7,238,095		7,108,397			7,100,571			(4)(7)
						7,094,745			7,086,095
Navicure, Inc.			Health Care Technology
First Lien Term Loan, LIBOR+4.00% cash due 9/18/2026	6.13	%		4,000,000		3,980,000			4,005,000			(4)(11)
						3,980,000			4,005,000

16

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

September 30, 2019

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost			Fair Value			Notes
Numericable SFR SA			Integrated Telecommunication Services
Fixed Rate Bond, 7.38% cash due 5/1/2026				$	380,000	$	380,950		$	408,865		(9)
						380,950			408,865
OEConnection LLC			Application Software
First Lien Delayed Draw Term Loan, LIBOR+4.00% cash due 9/24/2026				—		(4,086		)	(1,532		)	(4)(8)(11)
First Lien Term Loan, LIBOR+4.00% cash due 9/24/2026	6.13	%		8,682,796		8,639,382			8,666,515			(4)(11)
						8,635,296			8,664,983
P & L Development, LLC			Pharmaceuticals
First Lien Term Loan, LIBOR+7.50% cash due 6/28/2024	9.55	%		4,110,000		4,011,515			4,068,900			(4)(7)
						4,011,515			4,068,900
PaySimple, Inc.			Data Processing & Outsourced Services
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 8/23/2025				—		(53,281		)	(40,425		)	(4)(7)(8)(11)
First Lien Term Loan, LIBOR+5.50% cash due 8/23/2025	7.55	%		8,305,000		8,140,807			8,180,425			(4)(7)(11)
						8,087,526			8,140,000
ProFrac Services, LLC			Industrial Machinery
First Lien Term Loan, LIBOR+6.25% cash due 9/15/2023	8.66	%		1,409,167		1,397,985			1,380,983			(4)(7)(11)
						1,397,985			1,380,983
Project Boost Purchaser, LLC			Application Software
First Lien Term Loan, LIBOR+3.50% cash due 6/1/2026	5.54	%		2,800,000		2,772,000			2,785,650			(4)
Second Lien Term Loan, LIBOR+8.00% cash due 5/9/2027	10.14	%		1,500,000		1,500,000			1,500,000			(4)(7)
						4,272,000			4,285,650
Recorded Books Inc.			Publishing
First Lien Term Loan, LIBOR+4.50% cash due 8/29/2025	6.54	%		1,980,000		1,960,200			1,984,960			(4)(11)
						1,960,200			1,984,960
Scilex Pharmaceuticals Inc.			Pharmaceuticals
Fixed Rate Zero Coupon Bond, cash due 8/15/2026				2,381,775		1,671,956			1,702,969			(7)
						1,671,956			1,702,969
Signify Health, LLC			Health Care Services
First Lien Term Loan, LIBOR+4.50% cash due 12/23/2024	6.60	%		6,964,646		6,899,566			6,955,941			(4)(11)
						6,899,566			6,955,941
Sirva Worldwide, Inc.			Diversified Support Services
First Lien Term Loan, LIBOR+5.50% cash due 8/4/2025	7.54	%		1,962,500		1,933,062			1,903,625			(4)
						1,933,062			1,903,625
Sorrento Therapeutics, Inc.			Biotechnology
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 11/7/2023				—		(19,689		)	(22,080		)	(4)(7)(8)(9)
First Lien Term Loan, LIBOR+7.00% cash due 11/7/2023	9.13	%		9,600,000		9,002,287			9,360,000			(4)(7)(9)
Stock Warrants (exercise price $3.28) expiration date 5/7/2029						560,000			533,306			(7)(9)
Stock Warrants (exercise price $3.94) expiration date 11/3/2029						—			102,397			(7)(9)
						9,542,598			9,973,623
StandardAero Aviation Holdings Inc.			Aerospace & Defense
First Lien Term Loan, LIBOR+4.00% cash due 4/6/2026	6.10	%		3,000,000		2,996,318			3,017,805			(4)
						2,996,318			3,017,805
Sunshine Luxembourg VII SARL			Personal Products
First Lien Term Loan, LIBOR+4.25% cash due 9/25/2026	6.59	%		5,000,000		4,975,000			5,029,700			(4)(9)
						4,975,000			5,029,700
TIBCO Software Inc.			Application Software
First Lien Term Loan, LIBOR+4.00% cash due 6/30/2026	6.07	%		9,484,693		9,496,896			9,510,397			(4)(11)
						9,496,896			9,510,397

17

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

September 30, 2019

Portfolio Company/Type of Investment (1)(2)(3)	Cash Interest Rate (4)		Industry	Principal (5)		Cost		Fair Value		Notes
Transact Holdings Inc.			Application Software
First Lien Term Loan, LIBOR+4.75% cash due 4/30/2026	7.01	%		$	8,000,000	$	7,880,000	$	7,960,000	(4)
						7,880,000		7,960,000
Tullow Oil PLC			Oil & Gas Exploration & Production
Fixed Rate Callable Bond, 6.25% cash due 4/15/2022				700,000		691,321		709,800		(9)
						691,321		709,800
Uber Technologies, Inc.			Application Software
First Lien Term Loan, LIBOR+3.50% cash due 7/13/2023	5.55	%		3,969,309		3,954,413		3,948,649		(4)
First Lien Term Loan, LIBOR+4.00% cash due 4/4/2025	6.03	%		981,065		974,542		977,185		(4)
						4,928,955		4,925,834
UFC Holdings, LLC			Movies & Entertainment
First Lien Term Loan, LIBOR+3.25% cash due 4/29/2026	5.30	%		3,491,003		3,491,003		3,504,338		(4)
						3,491,003		3,504,338
Uniti Group LP			Specialized REITs
First Lien Term Loan, LIBOR+5.00% cash due 10/24/2022	7.04	%		3,429,488		3,345,831		3,351,793		(4)(9)(11)
						3,345,831		3,351,793
UOS, LLC			Trading Companies & Distributors
First Lien Term Loan, LIBOR+5.50% cash due 4/18/2023	7.54	%		2,969,620		2,990,975		3,006,741		(4)(11)
						2,990,975		3,006,741
Veritas US Inc.			Application Software
First Lien Term Loan, LIBOR+4.50% cash due 1/27/2023	6.60	%		4,315,150		4,099,814		4,089,619		(4)(11)
						4,099,814		4,089,619
Verscend Holding Corp.			Health Care Technology
First Lien Term Loan, LIBOR+4.50% cash due 8/27/2025	6.54	%		8,369,747		8,374,824		8,413,353		(4)(11)
						8,374,824		8,413,353
WeddingWire, Inc.			Interactive Media & Services
First Lien Term Loan, LIBOR+4.50% cash due 12/19/2025	6.54	%		2,977,500		2,964,142		2,981,222		(4)(11)
						2,964,142		2,981,222
WideOpenWest Finance, LLC			Cable & Satellite
First Lien Term Loan, LIBOR+3.25% cash due 8/18/2023	5.29	%		4,383,110		4,258,195		4,246,138		(4)(9)
						4,258,195		4,246,138
WP CPP Holdings, LLC			Aerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/2025	6.01	%		3,969,925		3,945,385		3,981,100		(4)(11)
						3,945,385		3,981,100
Zillow Group, Inc.			Interactive Media & Services
Fixed Rate Bond, 1.50% cash due 7/1/2023				497,000		471,430		438,913		(9)
						471,430		438,913
Total Non-Control/Non-Affiliate Investments (169.6% of net assets)						$	289,322,834	$	291,147,011
Cash and Cash Equivalents and Restricted Cash (6.6% of net assets)						$	11,348,126	$	11,348,126
Total Portfolio Investments, Cash and Cash Equivalents and Restricted Cash (176.3% of net assets)						$	300,670,960	$	302,495,137

Derivative Instrument	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Counterparty	Cumulative Unrealized Appreciation (Depreciation)
Foreign currency forward contract	$	2,798,483	€	2,475,000	1/16/2020	Bank of New York Mellon	$	77,558

18

Oaktree Strategic Income II, Inc.

Consolidated Schedule of Investments

September 30, 2019

(1) All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.

(2) See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.

(3) Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.

(4) The interest rate on the principal balance outstanding for all floating rate loans is indexed to the LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate based rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2019, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 2.04%, the 60-day LIBOR at 2.09%, the 90-day LIBOR at 2.10% and the 30-day EURIBOR at (0.51)%. Most loans include an interest floor, which generally ranges from 0% to 1%.

(5) "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.

(6) Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. Control Investments generally are defined by the Investment Company Act, as investments in companies in which the Company owns more than 25% of the voting securities and/or has the power to exercise control over the management or policies of the company. Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.

(7) As of September 30, 2019, these investments are categorized as Level 3 within the fair value hierarchy established by ASC 820 and were valued using significant unobservable inputs.

(8) Investment has undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

(9) Investment is not a qualifying asset as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2019, qualifying assets represented 80.1% of the Company's total assets and non-qualifying assets represented 19.9% of the Company's total assets.

(10) PIK interest income for this investment accrues at an annualized rate of 15%, however, the PIK interest is not contractually capitalized on the investment. As a result, the principal amount of the investment does not increase over time for accumulated PIK interest. As of September 30, 2019, the accumulated PIK interest balance for each of the Alvotech A notes and the B notes was $0.2 million. The fair value of this investment is inclusive of PIK.

(11) This investment is pledged as collateral under the Citibank Facility (as defined in Note 6 to the accompanying notes to the Consolidated Financial Statements).

See notes to Consolidated Financial Statements.

19

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Organization

Oaktree Strategic Income II, Inc. (together with its consolidated subsidiaries, where applicable, the "Company") is structured as a closed-end investment company focused on lending to small- and medium-sized companies. The Company has elected to be regulated as a business development company (a "BDC") under the Investment Company Act of 1940, as amended (the "Investment Company Act") and has elected to be treated, and intends to comply with the requirements to qualify annually, as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (together with the rules and regulations promulgated thereunder, the "Code").

The Company was formed on April 30, 2018 as a Delaware corporation and as of March 31, 2020 is externally managed by Oaktree Capital Management, L.P. (the "Adviser"), a subsidiary of Oaktree Capital Group, LLC ("OCG"). In 2019, Brookfield Asset Management Inc. ("Brookfield") acquired a majority economic interest in OCG. OCG operates as an independent business within Brookfield, with its own product offerings and investment, marketing and support teams.

The Company conducts private offerings (each, a “Private Offering”) of its common stock ("Common Stock") to investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). At each closing of a Private Offering, each investor participating in that closing makes a capital commitment (each, a “Capital Commitment”) to purchase the Company's Common Stock pursuant to a subscription agreement entered into with the Company in connection with its Capital Commitment ("Subscription Agreement"). Investors are required to fund drawdowns to purchase the Company's Common Stock up to the amount of their respective Capital Commitments on an as-needed basis with a minimum of ten calendar days' prior notice (excluding the initial drawdown for each investor). On July 23, 2018, the Company was initially capitalized with a $1,000 investment by the Adviser. The initial closing of a Private Offering occurred on August 6, 2018 (the "Initial Closing"). The Company's operations commenced on August 6, 2018, and loan origination and investment activities commenced shortly after the Initial Closing. As of March 31, 2020, the Company received $337,683,996 in Capital Commitments from investors in connection with Private Offerings.

The Company seeks to invest opportunistically across asset classes and geographies, primarily in the form of senior loans, and to a lesser extent, high yield bonds, to borrowers that are in need of direct loans, rescue financings or other capital solutions or that have had challenged or unsuccessful primary offerings. The Company's investment objective is to generate current income and long-term capital appreciation. The Company seeks to achieve its investment objective without subjecting principal to undue risk of loss by lending to and investing in the debt of public and private companies, primarily in situations where a company or its owners are (a) overleveraged or facing pressure to recapitalize, (b) unable to access broadly syndicated capital markets, (c) undervalued after having recently exited bankruptcy, completed a restructuring or are in a cyclically out-of-favor industry or (d) otherwise affected by mispricings or inefficiencies in the capital markets or at different points throughout the credit cycle.

Note 2. Significant Accounting Policies

Basis of Presentation:

The consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the consolidated financial statements have been made. All intercompany balances and transactions have been eliminated in consolidation. Certain prior-period financial information has been reclassified to conform to current period presentation. The Company is an investment company following the accounting and reporting guidance in FASB ASC Topic 946, Financial Services - Investment Companies ("ASC 946").

Use of Estimates:

The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.

20

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Consolidation:

The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries, OSI 2 AB Blocker LLC and OSI 2 Senior Lending SPV, LLC. OSI 2 AB Blocker LLC and OSI 2 Senior Lending SPV, LLC are wholly-owned and, as such, consolidated into the consolidated financial statements. Certain subsidiaries of the Company that hold investments are treated as pass through entities for tax purposes. The assets of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of the Company. As an investment company, portfolio investments held by the Company are not consolidated into the consolidated financial statements but rather are included on the Consolidated Statements of Assets and Liabilities as investments at fair value.

Fair Value Measurements:

The Company's board of directors, with the assistance of its audit committee (the “Audit Committee”) and the Adviser, determines the fair value of its assets on at least a quarterly basis, in accordance with the terms of FASB ASC Topic 820, Fair Value Measurement. The Audit Committee is comprised of independent directors. The Company's investments are valued at fair value. For purposes of periodic reporting, the Company values its assets in accordance with GAAP and based on the principles and methods of valuation summarized below. GAAP requires that a “fair value” be assigned to all assets and establishes a single authoritative definition of fair value that includes a framework for measuring fair value and enhanced disclosures about fair value measurements.

GAAP establishes a hierarchal disclosure framework, which prioritizes the inputs used in measuring financial instruments at fair value into three levels based on their market price observability. Market price observability is affected by a number of factors, including the type of instrument and the characteristics specific to the instrument. Financial instruments with readily available quoted prices from an active market or for which fair value can be measured based on actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value.

Financial assets and liabilities measured and reported at fair value are classified as follows:

• Level I - Quoted unadjusted prices for identical instruments in active markets to which the Company has access at the date of measurement.

• Level II - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are directly or indirectly observable.

• Level III - Valuations for which one or more significant inputs are unobservable. These inputs reflect our assessment of the assumptions that market participants use to value the investment based on the best available information. Level III inputs include prices obtained from brokers in markets for which there are few transactions, less public information exists or prices vary among broker market makers.

In some instances, an instrument may fall into different levels of the fair value hierarchy. In such instances, the instrument’s level within the fair value hierarchy is based on the lowest of the three levels (with Level III being the lowest) that is significant to the value measurement. The assessment of the significance of an input requires judgment and considers factors specific to the instrument. The transfer of assets into or out of each fair value hierarchy level as a result of changes in the observability of the inputs used in measuring fair value are accounted for as of the beginning of the reporting period. Transfers resulting from a specific event, such as a reorganization or restructuring, are accounted for as of the date of the event that caused the transfer.

In the absence of observable market prices, the Company values Level III investments using valuation methodologies applied on a consistent basis. The quarterly valuation process for Level III investments begins with each portfolio company, property or security being initially valued by the Adviser's valuation team in conjunction with the investment team. The preliminary valuations are then reviewed and approved by the valuation team, the valuation committee, which consists of senior members of the investment team, and designated investment professionals as well as the valuation officer who is independent of the investment teams. The Audit Committee reviews the preliminary valuations provided by the valuation committee and makes a recommendation to the Company's full board of directors regarding the fair value of the investments in our portfolio. The Company's board of directors ultimately determines in good faith the fair value of each investment in the Company's portfolio. Results of the valuation process are evaluated each quarter, including an assessment of whether the underlying calculations should be adjusted or recalibrated. In connection with this process, the Company evaluates changes in fair value measurements from period to period for reasonableness, considering items such as industry trends, general economic and market conditions, and factors specific to the investment.

Certain Level III assets are valued using prices obtained from pricing vendors or brokers. These investments are classified as Level III because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustment for investment-specific factors or restrictions. The Company seeks to obtain at least two quotations for the

21

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

subject or similar securities, typically from pricing vendors. If the Company is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within the Company's set threshold, the Company seeks to obtain a quote directly from a broker making a market for the asset. However, given the nature of our portfolio, the Company does not expect that all of our Level III assets will be valued at least annually using prices obtained from pricing vendors or brokers. Generally, the Company does not adjust any of the prices received from these sources, and all prices are reviewed by the Company. The Company evaluates the prices obtained from pricing vendors or brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. The Adviser also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, the Adviser performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process.

Non-publicly traded debt and equity securities and other securities or instruments for which reliable market quotations are not available are valued by the Company using valuation methodologies applied on a consistent basis. These securities may initially be valued at the acquisition price as the best indicator of fair value. The Company reviews the significant unobservable inputs, valuations of comparable investments and other similar transactions for investments valued at acquisition price to determine whether another valuation methodology should be utilized. Subsequent valuations will depend on facts and circumstances known as of the valuation date and the application of valuation methodologies further described below under “– Non-Exchange-Traded Investments.” The fair value may also be based on a pending transaction expected to close after the valuation date. These valuation methodologies involve a significant degree of management judgment. Accordingly, valuations do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments in the future. Fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to the consolidated financial statements.

Exchange-Traded Investments

Securities listed on one or more national securities exchanges are valued at their last reported sales price on the date of valuation. If no sale occurred on the valuation date, the security is valued at the mean of the last “bid” and “ask” prices on the valuation date. Securities that are not marketable due to legal restrictions that may limit or restrict transferability are generally valued at a discount from quoted market prices. The discount would reflect the amount market participants would require due to the risk relating to the inability to access a public market for the security for the specified period and would vary depending on the nature and duration of the restriction and the risk and volatility of the underlying securities. Securities with longer duration restrictions or higher volatility are generally valued at a higher discount. Such discounts are generally estimated based on put option models or analysis of market studies. Instances where discounts have been applied to quoted prices of restricted listed securities have been infrequent. The impact of such discounts is not material to the consolidated financial statements.

Non-Exchange-Traded Investments

Investments in corporate and government debt which are not listed or admitted to trading on any securities exchange are valued at the mean of the last bid and ask prices on the valuation date based on quotations supplied by recognized quotation services or by reputable broker dealers.

If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, the Company values such investments using different valuation techniques. One valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The market yield technique is considered in the valuation of non-publicly traded debt investments, utilizing expected future cash flows, discounted using estimated current market rates. Discounted cash flow calculations may be adjusted to reflect current market conditions and/or the perceived credit risk of the borrowers. Consideration is also given to a borrower’s ability to meet principal and interest obligations; this may include an evaluation of collateral or the underlying value of the borrower, utilizing either the market or income techniques. A market technique utilizes valuations of comparable public companies or transactions and generally seeks to establish the enterprise value of the portfolio company using a market multiple technique. This technique takes into account a specific financial measure (such as earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA, free cash flow, net operating income, net income, book value or net asset value) believed to be most relevant for the given company. Consideration may also be given to such factors as acquisition price of the security, historical and projected operational and financial results for the portfolio company, the strengths and weaknesses of the portfolio company relative to its comparable companies, industry trends, general economic and market conditions and other factors deemed relevant. The income technique is typically a discounted cash flow method that incorporates expected timing and level of cash flows. It incorporates assumptions in determining growth rates, income and expense projections, discount rates, capital structure, terminal values and other factors. The applicability and weight assigned to market and income techniques are determined based on the availability of reliable projections and comparable companies and transactions.

The valuation of securities may be impacted by expectations of investors’ receptiveness to a public offering of the securities, the size of the holding of the securities and any associated control, information with respect to transactions or offers for the securities

22

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(including the transaction pursuant to which the investment was made and the period of time elapsed from the date of the investment to the valuation date) and applicable restrictions on the transferability of the securities.

Investments made by the Company are, by nature, generally considered to be long-term investments and are not intended to be liquidated on a short-term basis. Additionally, these valuation methodologies involve a significant degree of management judgment. Accordingly, valuations by the Company do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments in the future. Estimated fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to the consolidated financial statements.

The Company may estimate the fair value of privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an enterprise value analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk-free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.

With the exception of the line items entitled "deferred financing costs," "other assets," and "credit facilities payable," which are reported at amortized cost, all assets and liabilities on the Consolidated Statements of Assets and Liabilities approximate fair value. The carrying value of the line items titled "interest receivable," "receivables from unsettled transactions," "receivable for shares sold," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliates," "interest payable," "deferred tax liability" and "payables from unsettled transactions" approximate fair value due to their short maturities.

Foreign Currency Translation:

The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.

Derivative Instruments:

The Company does not utilize hedge accounting and as such values its derivative instruments at fair value with the unrealized gains or losses recorded in “net unrealized appreciation (depreciation)” in the Company’s Consolidated Statements of Operations.

Investment Income:

Interest Income

Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations.

In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.

PIK Interest Income

The Company's investments in debt securities may contain payment-in-kind ("PIK") interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves

23

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the consolidated financial statements including for purposes of computing the capital gains incentive fee payable by the Company to the Adviser. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so.

Fee Income

The Adviser may provide financial advisory services to portfolio companies in connection with structuring a transaction and in return the Company may receive fees for capital structuring services. These fees are generally nonrecurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered.

The Company has also structured exit fees across certain of its portfolio investments to be received upon the future exit of those investments. These fees are typically paid to the Company upon the earliest to occur of (i) a sale of the borrower or substantially all of the assets of the borrower, (ii) the maturity date of the loan or (iii) the date when full prepayment of the loan occurs. The receipt of such fees is contingent upon the occurrence of one of the events listed above for each of the investments. These fees are included in net investment income over the life of the loan.

Cash and Cash Equivalents and Restricted Cash:

Cash and cash equivalents and restricted cash consist of demand deposits and highly liquid investments with maturities of three months or less, when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents and restricted cash are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.

As of March 31, 2020 and September 30, 2019, included in restricted cash was $2,247,126 and $269,111, respectively, which was held at Deutsche Bank Trust Company Americas in connection with the Company's Citibank Facility (defined in Note 6– Borrowings). The Company was restricted in terms of access to the $2,247,126 and $269,111 until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the Citibank Facility.

Organization and Offering Expenses:

Costs incurred to organize the Company were expensed as incurred. There were no organizational costs incurred during the three and six months ended March 31, 2020. For the three and six months ended March 31, 2019, the Company incurred organizational costs of $710 and $56,921, respectively.

Offering costs incurred in connection with Private Offerings were recognized as a deferred cost and amortized on a straight line basis over twelve months beginning on August 6, 2018 (commencement of operations). For the three and six months ended March 31, 2020, no additional offering costs were incurred. For the three and six months ended March 31, 2019, the Company capitalized additional offering costs of $24,244 and $120,992, respectively, and amortized $194,104 and $362,373, respectively, of deferred offering costs. Deferred offering costs were fully amortized as of August 6, 2019.

Receivables/Payables from Unsettled Transactions:

Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.

24

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Deferred Financing Costs:

Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities. Deferred financing costs incurred in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs incurred in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense.

Income Taxes:

The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and intends to operate in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each tax year. As a RIC, the Company is not subject to federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a tax year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next tax year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company incurred a U.S. federal excise tax of $14,515 for calendar year 2018 and did not incur a U.S. federal excise tax for calendar year 2019.

The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s consolidated financial statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.

FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented, and disclosed in the Company's consolidated financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more likely than not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2018 and 2019. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.

Recent Accounting Pronouncements:

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848)Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting if certain criteria are met. The guidance is effective from March 12, 2020 through December 31, 2022. As of March 31, 2020, the guidance did not have a material impact on the Consolidated Financial Statements.

25

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 3. Portfolio Investments

Portfolio Composition

 As of March 31, 2020, the fair value of the Company's investment portfolio was $354.7 million and was comprised of investments in 107 portfolio companies. As of September 30, 2019, the fair value of the Company's investment portfolio was $291.1 million and was comprised of investments in 69 portfolio companies.

As of March 31, 2020 and September 30, 2019, the Company's investment portfolio consisted of the following:

	March 31, 2020				September 30, 2019
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	372,648,045	95.50	%	$	281,238,755	97.20	%
Subordinated debt	16,393,453		4.20	%	7,201,102		2.49	%
Common equity & warrants	1,043,713		0.27	%	772,692		0.27	%
Preferred equity	110,285		0.03	%	110,285		0.04	%
Total	$	390,195,496	100.00	%	$	289,322,834	100.00	%

	March 31, 2020						September 30, 2019
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	338,700,828	95.49	%	168.49	%	$	282,841,206	97.14	%	164.80	%
Subordinated debt	14,717,002		4.15	%	7.32	%	7,325,965		2.52	%	4.27	%
Common equity & warrants	1,165,398		0.33	%	0.58	%	869,555		0.30	%	0.51	%
Preferred equity	113,593		0.03	%	0.06	%	110,285		0.04	%	0.06	%
Total	$	354,696,821	100.00	%	176.45	%	$	291,147,011	100.00	%	169.64	%

The composition of the Company's debt investments as of March 31, 2020 and September 30, 2019 by floating rates and fixed rates was as follows:

	March 31, 2020				September 30, 2019
	Fair Value		% of Debt Investments		Fair Value		% of Debt Investments
Floating rate	$	335,327,284	94.88	%	$	270,653,147	93.27	%
Fixed rate	18,090,546		5.12	%	19,514,024		6.73	%
Total	$	353,417,830	100.00	%	$	290,167,171	100.00	%

26

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The geographic composition of the Company's portfolio is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the portfolio composition by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:

	March 31, 2020				September 30, 2019
Cost:			% of Total Investments				% of Total Investments
United States	$	341,849,232	87.62	%	$	257,736,195	89.08	%
United Kingdom	18,280,245		4.68	%	11,021,595		3.81	%
Luxembourg	9,331,601		2.39	%	7,837,090		2.71	%
France	6,881,865		1.76	%	5,230,110		1.81	%
Australia	5,940,000		1.52	%	—		—	%
Iceland	4,739,872		1.21	%	4,406,462		1.52	%
Canada	3,172,681		0.82	%	2,875,400		0.99	%
Denmark	—		—	%	215,982		0.08	%
Total	$	390,195,496	100.00	%	$	289,322,834	100.00	%

	March 31, 2020						September 30, 2019
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
United States	$	310,661,023	87.58	%	154.53	%	$	259,279,171	89.06	%	151.07	%
United Kingdom	16,233,688		4.58	%	8.08	%	11,079,743		3.81	%	6.46	%
Luxembourg	8,188,335		2.31	%	4.07	%	7,697,297		2.64	%	4.48	%
France	6,892,687		1.94	%	3.43	%	5,282,695		1.81	%	3.08	%
Iceland	4,917,192		1.39	%	2.45	%	4,688,800		1.61	%	2.73	%
Australia	4,695,000		1.32	%	2.34	%	—		—	%	—	%
Canada	3,108,896		0.88	%	1.55	%	2,896,055		0.99	%	1.69	%
Denmark	—		—	%	—	%	223,250		0.08	%	0.13	%
Total	$	354,696,821	100.00	%	176.45	%	$	291,147,011	100.00	%	169.64	%

27

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of March 31, 2020 and September 30, 2019 was as follows:

	March 31, 2020				September 30, 2019
Cost:			% of Total Investments				% of Total Investments
Application Software	$	79,261,987	20.31	%	$	59,770,591	20.64	%
Personal Products	23,165,379		5.94	%	4,975,000		1.72	%
Health Care Technology	16,445,659		4.21	%	12,354,824		4.27	%
Integrated Telecommunication Services	16,231,884		4.16	%	18,343,050		6.34	%
Internet Services & Infrastructure	15,850,014		4.06	%	18,962,689		6.55	%
Biotechnology	15,385,608		3.94	%	20,067,414		6.94	%
Alternative Carriers	14,812,418		3.80	%	9,310,000		3.22	%
Oil & Gas Storage & Transportation	13,893,562		3.56	%	—		—	%
Health Care Services	12,809,774		3.28	%	10,956,005		3.79	%
Systems Software	12,042,033		3.09	%	13,237,985		4.58	%
Pharmaceuticals	10,926,284		2.80	%	8,545,561		2.95	%
Data Processing & Outsourced Services	9,878,916		2.53	%	8,087,526		2.80	%
Diversified Support Services	9,360,426		2.40	%	9,416,772		3.25	%
Real Estate Services	8,814,976		2.26	%	8,849,687		3.06	%
Specialized REITs	8,613,792		2.21	%	3,345,831		1.16	%
Distributors	8,415,294		2.16	%	—		—	%
Independent Power Producers & Energy Traders	8,107,555		2.08	%	—		—	%
Aerospace & Defense	8,030,121		2.06	%	6,941,703		2.40	%
Oil & Gas Refining & Marketing	7,840,800		2.01	%	7,880,400		2.72	%
Publishing	7,808,970		2.00	%	1,960,200		0.68	%
Airport Services	7,319,759		1.88	%	—		—	%
Movies & Entertainment	7,015,227		1.80	%	3,491,003		1.21	%
Research & Consulting Services	6,943,057		1.78	%	7,509,371		2.60	%
Auto Parts & Equipment	5,937,688		1.52	%	5,962,563		2.06	%
Health Care Supplies	5,778,000		1.48	%	—		—	%
Metal & Glass Containers	5,774,588		1.48	%	1,475,024		0.51	%
IT Consulting & Other Services	5,679,277		1.46	%	5,690,535		1.97	%
Industrial Machinery	5,300,405		1.36	%	1,397,985		0.48	%
Multi-Sector Holdings	4,216,307		1.08	%	—		—	%
Managed Health Care	3,944,241		1.01	%	3,952,935		1.37	%
Interactive Media & Services	3,832,821		0.98	%	6,704,549		2.32	%
Construction Materials	3,615,023		0.93	%	—		—	%
Trading Companies & Distributors	2,973,132		0.76	%	2,990,975		1.03	%
Communications Equipment	2,370,459		0.61	%	—		—	%
Restaurants	2,241,439		0.57	%	—		—	%
Household Products	1,922,892		0.49	%	1,910,503		0.66	%
Property & Casualty Insurance	1,378,246		0.35	%	—		—	%
Cable & Satellite	1,104,782		0.28	%	4,258,195		1.47	%
Specialized Finance	1,017,926		0.26	%	797,357		0.28	%
Environmental & Facilities Services	794,519		0.20	%	—		—	%
Building Products	584,660		0.15	%	—		—	%
Construction & Engineering	575,947		0.15	%	1,020,274		0.35	%
Specialty Stores	529,200		0.14	%	—		—	%
Food Retail	455,270		0.12	%	964,897		0.33	%
Oil & Gas Equipment & Services	364,100		0.09	%	849,160		0.29	%
Leisure Facilities	292,517		0.07	%	—		—	%
Casinos & Gaming	284,245		0.07	%	—		—	%
Health Care Facilities	254,317		0.07	%	—		—	%
Financial Exchanges & Data	—		—	%	5,591,298		1.93	%
Health Care Equipment	—		—	%	4,937,625		1.71	%
Insurance Brokers	—		—	%	3,903,391		1.35	%
Electric Utilities	—		—	%	1,202,830		0.42	%
Health Care Distributors	—		—	%	1,015,805		0.35	%
Oil & Gas Exploration & Production	—		—	%	691,321		0.24	%
Total	$	390,195,496	100.00	%	$	289,322,834	100.00	%

28

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	March 31, 2020						September 30, 2019
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Application Software	$	71,534,955	20.18	%	35.60	%	$	60,022,674	20.64	%	34.97	%
Personal Products	21,789,886		6.14	%	10.84	%	5,029,700		1.73	%	2.93	%
Integrated Telecommunication Services	16,005,395		4.51	%	7.96	%	18,571,805		6.38	%	10.82	%
Health Care Technology	15,788,684		4.45	%	7.85	%	12,418,353		4.27	%	7.24	%
Biotechnology	15,566,316		4.39	%	7.74	%	20,798,972		7.14	%	12.12	%
Internet Services & Infrastructure	14,593,360		4.11	%	7.26	%	18,992,309		6.52	%	11.07	%
Alternative Carriers	13,107,790		3.70	%	6.52	%	9,367,143		3.22	%	5.46	%
Oil & Gas Storage & Transportation	12,971,638		3.66	%	6.45	%	—		—	%	0.00	%
Health Care Services	11,612,259		3.27	%	5.78	%	10,992,559		3.78	%	6.40	%
Systems Software	10,497,894		2.96	%	5.22	%	13,126,771		4.51	%	7.65	%
Pharmaceuticals	9,729,897		2.74	%	4.84	%	8,439,466		2.90	%	4.92	%
Data Processing & Outsourced Services	9,093,773		2.56	%	4.52	%	8,140,000		2.80	%	4.74	%
Specialized REITs	7,868,823		2.22	%	3.91	%	3,351,793		1.15	%	1.95	%
Independent Power Producers & Energy Traders	7,816,770		2.20	%	3.89	%	—		—	%	—	%
Real Estate Services	7,815,938		2.20	%	3.89	%	8,887,725		3.05	%	5.18	%
Diversified Support Services	7,642,047		2.15	%	3.80	%	9,374,839		3.22	%	5.46	%
Distributors	7,077,052		2.00	%	3.52	%	—		—	%	0.00	%
Airport Services	7,051,125		1.99	%	3.51	%	—		—	%	—	%
Oil & Gas Refining & Marketing	7,009,200		1.98	%	3.49	%	8,009,750		2.75	%	4.67	%
Aerospace & Defense	6,960,633		1.96	%	3.46	%	6,998,905		2.40	%	4.08	%
Publishing	6,944,669		1.96	%	3.45	%	1,984,960		0.68	%	1.16	%
Research & Consulting Services	5,943,191		1.68	%	2.96	%	7,977,900		2.74	%	4.65	%
Movies & Entertainment	5,817,440		1.64	%	2.89	%	3,504,338		1.20	%	2.04	%
Metal & Glass Containers	5,181,761		1.46	%	2.58	%	1,397,930		0.48	%	0.81	%
Health Care Supplies	5,106,640		1.44	%	2.54	%	—		—	%	—	%
Auto Parts & Equipment	4,933,813		1.39	%	2.45	%	5,835,172		2.00	%	3.40	%
Industrial Machinery	4,660,984		1.31	%	2.32	%	1,380,983		0.47	%	0.80	%
IT Consulting & Other Services	4,629,405		1.31	%	2.30	%	5,341,103		1.83	%	3.11	%
Multi-Sector Holdings	3,581,149		1.01	%	1.78	%	—		—	%	—	%
Interactive Media & Services	3,559,282		1.00	%	1.77	%	6,735,570		2.31	%	3.92	%
Construction Materials	3,528,527		0.99	%	1.76	%	—		—	%	0.00	%
Managed Health Care	3,444,050		0.97	%	1.71	%	3,975,050		1.37	%	2.32	%
Trading Companies & Distributors	2,548,360		0.72	%	1.27	%	3,006,741		1.03	%	1.75	%
Communications Equipment	2,367,152		0.67	%	1.18	%	—		—	%	—	%
Household Products	1,809,170		0.51	%	0.90	%	1,902,500		0.65	%	1.11	%
Restaurants	1,758,278		0.50	%	0.87	%	—		—	%	—	%
Property & Casualty Insurance	1,309,752		0.37	%	0.65	%	—		—	%	—	%
Cable & Satellite	1,141,251		0.32	%	0.57	%	4,246,138		1.46	%	2.47	%
Specialized Finance	874,555		0.25	%	0.44	%	799,220		0.27	%	0.47	%
Environmental & Facilities Services	839,118		0.24	%	0.42	%	—		—	%	—	%
Building Products	566,269		0.16	%	0.28	%	—		—	%	—	%
Specialty Stores	565,438		0.16	%	0.28	%	—		—	%	—	%
Food Retail	460,608		0.13	%	0.23	%	993,555		0.34	%	0.58	%
Construction & Engineering	437,218		0.12	%	0.22	%	1,002,800		0.34	%	0.58	%
Leisure Facilities	313,044		0.09	%	0.16	%	—		—	%	0.00	%
Oil & Gas Equipment & Services	298,384		0.08	%	0.15	%	876,330		0.30	%	0.51	%
Casinos & Gaming	286,598		0.08	%	0.14	%	—		—	%	0.00	%
Health Care Facilities	257,280		0.07	%	0.13	%	—		—	%	0.00	%
Financial Exchanges & Data	—		—	%	—	%	5,673,531		1.95	%	3.31	%
Health Care Equipment	—		—	%	—	%	4,996,851		1.72	%	2.91	%
Insurance Brokers	—		—	%	—	%	3,930,369		1.35	%	2.29	%
Electric Utilities	—		—	%	—	%	1,227,156		0.42	%	0.72	%
Health Care Distributors	—		—	%	—	%	1,126,250		0.39	%	0.66	%
Oil & Gas Exploration & Production	—		—	%	—	%	709,800		0.24	%	0.41	%
Total	$	354,696,821	100.00	%	176.45	%	$	291,147,011	100.00	%	169.64	%

29

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fair Value Measurements

The following table presents the financial instruments carried at fair value as of March 31, 2020 on the Company's Consolidated Statements of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Total
Senior secured debt	$	—	$	207,604,083	$	131,096,745	$	338,700,828
Subordinated debt	—		13,007,852		1,709,150		14,717,002
Common equity & warrants	—		—		1,165,398		1,165,398
Preferred equity	—		—		113,593		113,593
Total investments at fair value	—		220,611,935		134,084,886		354,696,821
Derivative assets	—		55,258		—		55,258
Total assets at fair value	$	—	$	220,667,193	$	134,084,886	$	354,752,079

The following table presents the financial instruments carried at fair value as of September 30, 2019 on the Company's Consolidated Statements of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:

	Level 1		Level 2		Level 3		Total
Senior secured debt	$	—	$	219,518,979	$	63,322,227	$	282,841,206
Subordinated debt	—		5,622,996		1,702,969		7,325,965
Common equity & warrants	149,276		—		720,279		869,555
Preferred equity	—		—		110,285		110,285
Total investments at fair value	149,276		225,141,975		65,855,760		291,147,011
Derivative assets	—		77,558		—		77,558
Total assets at fair value	$	149,276	$	225,219,533	$	65,855,760	$	291,224,569

When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology.

The principal value of the Company's credit facilities approximates fair value due to their variable rates and are included in Level 3 of the hierarchy.

30

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table provides a roll-forward of the changes in fair value from December 31, 2019 to March 31, 2020, for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Senior Secured Debt			Subordinated Debt			Preferred Equity		Common Equity & Warrants			Total
Fair value as of December 31, 2019	$	105,793,635		$	1,745,616		$	112,490	$	2,010,417		$	109,662,158
Purchases	40,892,372			—			—		—			40,892,372
Sales and repayments	(4,656,903		)	(17,540		)	—		—			(4,674,443		)
PIK interest income	374,393			—			—		—			374,393
Accretion of OID	370,941			46,891			—		—			417,832
Net unrealized appreciation (depreciation)	(11,677,693		)	(65,817		)	1,103		(845,019		)	(12,587,426		)
Fair value as of March 31, 2020	$	131,096,745		$	1,709,150		$	113,593	$	1,165,398		$	134,084,886
Net unrealized appreciation (depreciation) relating to Level 3 assets still held at March 31, 2020 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended March 31, 2020	$	(11,677,693	)	$	(65,817	)	$	1,103	$	(845,019	)	$	(12,587,426	)

The following table provides a roll-forward in the changes in fair value from December 31, 2018 to March 31, 2019, for all investments for which the Company determined fair value using unobservable (Level 3) factors:        

	Senior Secured Debt			Subordinated Debt			Common Equity & Warrants		Total
Fair value as of December 31, 2018	$	26,757,663		$	1,560,000		$	530,489	$	28,848,152
Purchases	13,500,508			—			—		13,500,508
Sales and repayments	(649,083		)	(4,691		)	—		(653,774		)
Transfers in (a)	2,825,724			—			—		2,825,724
Transfers out (a)	(1,972,556		)	—			—		(1,972,556		)
PIK interest income	26,686			—			—		26,686
Accretion of OID	75,228			43,837			—		119,065
Net unrealized appreciation (depreciation)	418,948			5,711			976,051		1,400,710
Fair value as of March 31, 2019	$	40,983,118		$	1,604,857		$	1,506,540	$	44,094,515
Net unrealized appreciation (depreciation) relating to Level 3 assets and liabilities still held at March 31, 2019 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended March 31, 2019	$	418,948		$	5,711		$	976,051	$	1,400,710

__________

(a) There were transfers in/out of Level 3 from/to Level 2 for certain investments during the three months ended March 31, 2019 as a result of a change in the number of market quotes available and/or a change in market liquidity.

31

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table provides a roll-forward of the changes in fair value from September 30, 2019 to March 31, 2020, for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Senior Secured Debt			Subordinated Debt			Preferred Equity		Common Equity & Warrants		Total
Fair value as of September 30, 2019	$	63,322,227		$	1,702,969		$	110,285	$	720,279	$	65,855,760
Purchases	74,183,503			—			—		401,000		74,584,503
Sales and repayments	(6,791,516		)	(24,327		)	—		—		(6,815,843		)
Transfers in (a)	10,627,597			—			—		—		10,627,597
PIK interest income	525,625			—			—		—		525,625
Accretion of OID	501,115			92,622			—		—		593,737
Net unrealized appreciation (depreciation)	(11,271,806		)	(62,114		)	3,308		44,119		(11,286,493		)
Fair value as of March 31, 2020	$	131,096,745		$	1,709,150		$	113,593	$	1,165,398	$	134,084,886
Net unrealized appreciation (depreciation) relating to Level 3 assets still held at March 31, 2020 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the six months ended March 31, 2020	$	(11,230,136	)	$	(62,114	)	$	3,308	$	44,119	$	(11,244,823	)

__________

(a) There were transfers into Level 3 from Level 2 for certain investments during the six months ended March 31, 2020 as a result of a decreased number of market quotes available and/or decreased market liquidity.

The following table provides a roll-forward of the changes in fair value from September 30, 2018 to March 31, 2019, for all investments for which the Company determined fair value using unobservable (Level 3) factors:

	Senior Secured Debt			Subordinated Debt			Common Equity & Warrants		Total
Fair value as of September 30, 2018	$	11,655,202		$	1,500,000		$	—	$	13,155,202
Purchases	27,155,069			—			642,713		27,797,782
Sales and repayments	(664,832		)	(4,691		)	—		(669,523		)
Transfers in (a)	4,403,249			—			—		4,403,249
Transfers out (a)	(2,022,500		)	—			—		(2,022,500		)
PIK interest income	65,740			—			—		65,740
Accretion of OID	105,759			99,404			—		205,163
Net unrealized appreciation (depreciation)	285,431			10,144			863,827		1,159,402
Fair value as of March 31, 2019	$	40,983,118		$	1,604,857		$	1,506,540	$	44,094,515
Net unrealized appreciation (depreciation) relating to Level 3 assets and liabilities still held at March 31, 2019 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the six months ended March 31, 2019	$	285,431		$	10,144		$	863,827	$	1,159,402

__________

(a) There were transfers in/out of Level 3 from/to Level 2 for certain investments during the six months ended March 31, 2019 as a result of a change in the number of market quotes available and/or a change in market liquidity.

32

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Significant Unobservable Inputs for Level 3 Investments

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value as of March 31, 2020:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior secured debt	$	78,333,881	Market Yield	Market Yield	(b)	8.0%	-	21.0%	10.6%
	4,752,475		Transactions Precedent	Transaction Price	(e)	N/A	-	N/A	N/A
	48,010,389		Broker Quotations	Broker Quoted Price	(c)	N/A	-	N/A	N/A
Subordinated debt	1,709,150		Market Yield	Market Yield	(b)	15.0%	-	17.0%	16.0%
Common equity & warrants & preferred equity	212,848		Enterprise Value	Revenue multiple	(d)	0.7x	-	0.9x	0.8x
	1,066,143		Enterprise Value	EBITDA multiple	(d)	18.0x	-	20.0x	19.0x
Total	$	134,084,886

_____________________

(a) Weighted averages are calculated based on fair value of investments.

(b) Used when market participant would take into account market yield when pricing the investment.

(c) The Company generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The Company evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Each quoted price is evaluated by the Audit Committee of the Company's Board of Directors in conjunction with additional information compiled by the Adviser.

(d) Used when market participant would use such multiple when pricing the investment.

(e) Used when there is an observable transaction or pending event for the investment.

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value as of September 30, 2019:

Asset	Fair Value		Valuation Technique	Unobservable Input	Range				Weighted Average (a)
Senior secured debt	$	31,341,878	Market Yield	Market Yield	(b)	8.0%	-	18.0%	11.0%
	30,480,349		Broker Quotations	Broker Quoted Price	(c)	N/A	-	N/A	N/A
	1,500,000		Transactions Precedent	Transaction Price	(e)	N/A	-	N/A	N/A
Subordinated debt	1,702,969		Market Yield	Market Yield	(b)	13.0%	-	15.0%	14.0%
Common equity & warrants & preferred equity	830,564		Enterprise Value	Asset Multiple	(d)	0.7x	-	0.9x	0.8x
Total	$	65,855,760

_____________________

(a) Weighted averages are calculated based on fair value of investments.

(b) Used when market participant would take into account market yield when pricing the investment.

(c) The Company generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The Company evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Each quoted price is evaluated by the Audit Committee of the Company's Board of Directors in conjunction with additional information compiled by the Adviser.

(d) Used when market participant would use such multiple when pricing the investment.

(e) Used when there is an observable transaction or pending event for the investment.

Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.

33

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Under the enterprise value technique, the significant unobservable input used in the fair value measurement of the Company's investments is the EBITDA, revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.

Note 4. Fee Income

For the three and six months ended March 31, 2020, the Company recorded total fee income of $447,367 and $577,314, of which $15,495 and $32,108, respectively, was recurring in nature. For the three and six months ended March 31, 2019, the Company recorded total fee income of $9,114 and $264,678, respectively, of which $9,114 and $20,177, respectively, was recurring in nature.

Note 5. Share Data and Distributions

Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to FASB ASC Topic 260-10, Earnings per Share, for the three and six months ended March 31, 2020 and 2019:

	Three months ended March 31, 2020			Three months ended March 31, 2019		Six months ended March 31, 2020			Six months ended March 31, 2019
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	(35,783,222	)	$	2,791,502	$	(30,504,795	)	$	2,112,409
Weighted average common shares outstanding	8,489,301			3,391,900		8,399,091			3,033,543
Earnings (loss) per common share — basic and diluted	$	(4.22	)	$	0.82	$	(3.63	)	$	0.70

Changes in Net Assets

The following table presents the changes in net assets for the three and six months ended March 31, 2020:

	Common Stock
	Shares	Par Value		Additional Paid-in-Capital		Accumulated Distributable Earnings (Loss)			Total Net Assets
Balance at September 30, 2019	8,309,861	$	8,310	$	168,819,173	$	2,799,267		$	171,626,750
Net investment income	—	—		—		1,897,085			1,897,085
Net unrealized appreciation (depreciation)	—	—		—		3,062,531			3,062,531
Net realized gains (losses)	—	—		—		324,057			324,057
Provision for income tax (expense) benefit	—	—		—		(5,246		)	(5,246		)
Distributions to stockholders	—	—		—		(5,069,014		)	(5,069,014		)
Balance at December 31, 2019	8,309,861	$	8,310	$	168,819,173	$	3,008,680		$	171,836,163
Net investment income	—	—		—		4,320,142			4,320,142
Net unrealized appreciation (depreciation)	—	—		—		(40,410,913		)	(40,410,913		)
Net realized gains (losses)	—	—		—		307,858			307,858
Provision for income tax (expense) benefit	—	—		—		(309		)	(309		)
Issuance of common stock	3,265,803	3,266		67,533,533		—			67,536,799
Distributions to stockholders	—	—		—		(2,576,058		)	(2,576,058		)
Balance at March 31, 2020	11,575,664	$	11,576	$	236,352,706	$	(35,350,600	)	$	201,013,682

34

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table presents the changes in net assets for the three and six months ended March 31, 2019:

	Common Stock
	Shares	Par Value		Additional Paid-in-Capital		Accumulated Distributable Earnings (Loss)			Total Net Assets
Balance at September 30, 2018	1,541,738	$	1,542	$	30,833,227	$	(462,452	)	$	30,372,317
Net investment income	—	—		—		274,523			274,523
Net unrealized appreciation (depreciation)	—	—		—		(963,085		)	(963,085		)
Net realized gains (losses)	—	—		—		9,469			9,469
Issuance of common stock	1,850,162	1,850		36,700,180		—			36,702,030
Balance at December 31, 2018	3,391,900	$	3,392	$	67,533,407	$	(1,141,545	)	$	66,395,254
Net investment income	—	—		—		296,143			296,143
Net unrealized appreciation (depreciation)	—	—		—		2,412,574			2,412,574
Net realized gains (losses)	—	—		—		82,785			82,785
Balance at March 31, 2019	3,391,900	$	3,392	$	67,533,407	$	1,649,957		$	69,186,756

Capital Activity

As of March 31, 2020, the Company received $337,683,996 in Capital Commitments from investors in connection with Private Offerings, of which $3,854,346 in Capital Commitments were made by one or more affiliates of the Adviser. As of March 31, 2020, the Company completed drawdowns of $236,378,797, or 70.0%, of such Capital Commitments.

The Company has the authority to issue 250,000,000 shares of Common Stock, $0.001 per share par value and 100,000,000 shares of preferred stock, $0.001 per share par value. The following table summarizes total shares issued and proceeds related to capital drawdowns delivered pursuant to the Subscription Agreements for the Company’s Common Stock through March 31, 2020:

	Shares Issued	Price per Share		Proceeds
August 6, 2018 (1)	770,869	$	20.00	$	15,417,385
September 17, 2018	770,869	20.00		15,417,384
October 29, 2018	1,060,964	19.85		21,060,130
November 15, 2018	789,198	19.82		15,641,900
April 29, 2019	1,655,314	20.40		33,768,400
August 30, 2019	1,631,324	20.70		33,768,400
September 23, 2019	1,631,323	20.70		33,768,399
March 26, 2020	3,265,803	20.68		67,536,799
Total	11,575,664			$	236,378,797

__________________

(1) Includes 50 shares issued to one or more affiliates of the Adviser on July 23, 2018.

Distributions

Distributions to common stockholders are recorded on the ex-dividend date. The Company is required to distribute dividends each tax year to its stockholders of an amount generally at least equal to 90% of its investment company taxable income, determined without regard to any deduction for dividends paid, in order to be eligible for tax benefits allowed to a RIC under Subchapter M of the Code. The Company anticipates paying out as a distribution all or substantially all of those amounts. The amount to be paid out as a dividend is determined by the board of directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment.

35

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table reflects the distributions per share that the Company has paid on its common stock during the six months ended March 31, 2020:

Record Date	Payment Date	Amount per Share		Cash Distribution
November 7, 2019	November 21, 2019	$	0.29	$	2,409,859
December 13, 2019	December 30, 2019	0.32		2,659,155
March 13, 2020	March 31, 2020	0.31		2,576,058
		$	0.92	$	7,645,072

No distributions were paid by the Company to stockholders during the six months ended March 31, 2019.

Note 6. Borrowings

CNB Facility

On October 16, 2018, the Company entered into a revolving credit agreement (the “Credit Agreement”) between the Company, as borrower, and City National Bank (“CNB”), as lender. As of March 31, 2020, the Credit Agreement provided for a senior secured revolving credit facility (the “CNB Facility”) of up to $60 million (the “Maximum Commitment”) in aggregate principal amount, subject to (i) the lesser of a percentage of unfunded commitments from certain classes of eligible investors in the Company and (ii) the Maximum Commitment and had a scheduled maturity date of October 15, 2020. On May 1, 2020, the Company repaid all borrowings outstanding under the CNB Facility, following which the CNB Facility was terminated.

Borrowings under the CNB Facility bore interest at a rate equal to (a) the London Interbank Offered Rate ("LIBOR") for the selected period plus 1.65% for LIBOR loans or (b) the prime rate of CNB minus 0.25% for prime rate loans. There was a non-usage fee of 25 basis points per year on the unused portion of the CNB Facility, payable quarterly.

The CNB Facility was secured by a first priority security interest, subject to customary exceptions, in (i) all Capital Commitments, (ii) the Company's right to make capital calls, receive payment of capital contributions from investors and enforce payment of capital commitments and capital contributions under the Subscription Agreements with investors and other operative documents and (iii) a cash collateral account into which the capital contributions from investors are made. The Company made customary representations and warranties and was required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities. The Company's borrowings, including under the CNB Facility, were subject to the leverage restrictions contained in the Investment Company Act.

As of March 31, 2020 and September 30, 2019, the Company had $55.0 million and $65.0 million outstanding under the CNB Facility, respectively. The Company’s borrowings under the CNB Facility bore interest at a weighted average interest rate of 3.46% and 4.20% for the six months ended March 31, 2020 and 2019, respectively. For the three and six months ended March 31, 2020, the Company recorded interest expense (inclusive of fees) of $813,287 and $1,603,860 related to the CNB Facility, respectively. For the three and six months ended March 31, 2019, the Company recorded interest expense (inclusive of fees) of $453,272 and $587,155, respectively, related to the Credit Facility.

Citibank Facility

On July 26, 2019 (the “Closing Date”), the Company and OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), a wholly-owned and consolidated subsidiary of the Company, entered into a loan and security agreement (the “Loan Agreement”) with the lenders from time to time party thereto and the other parties referenced below. Under the terms of the Loan Agreement, the Company serves as the collateral manager and seller and OSI 2 SPV serves as borrower with Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

The Loan Agreement provides for a senior secured revolving credit facility (the “Citibank Facility”) of up to $100 million (the “Maximum Commitment”) in aggregate principal amount, subject to the lesser of (i) the borrowing base, which is an amount based on advance rates that vary depending on the class of assets and the value assigned to such assets under the Loan Agreement and (ii) the Maximum Commitment. The Citibank Facility has a three year reinvestment period (the “Reinvestment Period”) during which advances may be made and matures five years from the Closing Date. Following the Reinvestment Period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender under the Loan Agreement, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) the LIBOR for a three month maturity and (b) for

36

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

all other lenders under the Citibank Facility, LIBOR, plus, in each case, an applicable spread. During the Reinvestment Period, the applicable spread is the greater of (i) a weighted average rate of (x) 1.65% per year for broadly syndicated loans and (y) 2.25% per year for all other eligible loans and (ii) 1.85%. After the Reinvestment Period, the applicable spread is 3.00% per year. There is also a non-usage fee of (i) 0.40% per year for the first six months following the Closing Date (the “Ramp-Up Period”) and (ii) 0.50% per year thereafter, in each case, on the unused portion of the Citibank Facility, payable quarterly; provided that if after the Ramp-Up Period the unused portion of the Citibank Facility is greater than 30% of the commitments under the Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the Citibank Facility.

The Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets.

As part of the Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including, but not limited to, restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the Citibank Facility.

Under the Citibank Facility, the Company and OSI 2 SPV, as applicable, have made customary representations and warranties, and are required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities.

OSI 2 SPV’s borrowings are non-recourse to the Company but are considered borrowings of the Company for purposes of complying with the asset coverage requirements under the Investment Company Act.

As of March 31, 2020 and September 30, 2019, the Company had $95.0 million and $18.0 million outstanding under the Citibank Facility, respectively. The Company’s borrowings under the Citibank Facility bore interest at a weighted average interest rate of 3.57% for the six months ended March 31, 2020. For the three and six months ended March 31, 2020, the Company recorded interest expense (inclusive of fees) of $818,689 and $1,383,309, respectively, related to the Citibank Facility.

Note 7. Taxable/Distributable Income and Dividend Distributions

Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments, as gains and losses are not included in taxable income until they are realized, (2) organizational and deferred offering costs and (3) the capital gains incentive fee accrual.

Listed below is a reconciliation of net increase (decrease) in net assets resulting from operations to taxable income for the three and six months ended March 31, 2020 and 2019:

	Three months ended March 31, 2020			Three months ended March 31, 2019			Six months ended March 31, 2020			Six months ended March 31, 2019
Net increase (decrease) in net assets resulting from operations	$	(35,783,222	)	$	2,791,502		$	(30,504,795	)	$	2,112,409
Net unrealized (appreciation) depreciation	40,410,913			(2,412,574		)	37,348,382			(1,449,489		)
Book/tax differences due to capital gains incentive fee	(1,104,890		)	350,369			(427,572		)	308,348
Book/tax difference due to organizational and deferred offering costs	(7,602		)	187,212			(15,204		)	404,090
Other book/tax differences	(21,991		)	—			(16,745		)	9,357
Taxable income (1)	$	3,493,208		$	916,509		$	6,384,066		$	1,384,715

__________________

(1) The Company's taxable income for the three and six months ended March 31, 2020 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2020. Therefore, the final taxable income may be different than the estimate.

For the three and six months ended March 31, 2020, the Company recognized a total provision for income taxes of $309 and $5,555, respectively, which was comprised of deferred income tax expense that resulted from unrealized appreciation on an investment held by a wholly-owned taxable subsidiary.

37

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

As of September 30, 2019, the Company's tax year end, the components of accumulated undistributed income on a tax basis were as follows:

Undistributed ordinary income, net	$	1,793,055
Net realized capital gains	$	642,220
Unrealized gains, net	$	363,992

The aggregate cost of investments for income tax purposes was $290,860,578 as of September 30, 2019. As of September 30, 2019, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for income tax purposes was $3,314,337. As of September 30, 2019, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for income tax purposes over value was $2,950,345. As of September 30, 2019, net unrealized appreciation based on the aggregate cost of investments for income tax purposes was $363,992.

Note 8. Concentration of Credit Risks

The Company deposits its cash with financial institutions and at times such balances may be in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

Note 9. Related Party Transactions

The Company has entered into an Investment Advisory Agreement with the Adviser. Pursuant to the Investment Advisory Agreement, the Company pays the Adviser a fee for investment advisory and management services consisting of two components - the Management Fee and the Incentive Fee (each as defined below).

Management Fee

Prior to (i) the listing of the Company’s Common Stock on a national securities exchange or (ii) an initial public offering of the Company’s Common Stock that results in gross proceeds to the Company of at least $50 million and a listing of the Common Stock on a national securities exchange (each of (i) and (ii), a “Qualified Listing”), if any, the Adviser is entitled to receive quarterly in arrears a management fee (the “Management Fee”) equal to 1.00% per annum (the “Applicable Management Fee Percentage”) of the Company’s Gross Asset Value (as defined below); provided, that prior to a Qualified Listing, the Management Fee does not exceed 1.75% per annum of the Unleveraged Asset Value (as defined below). From and after the date of a Qualified Listing, if any, the Applicable Management Fee Percentage will increase to 1.50% per annum of the Company’s Gross Asset Value.

For purposes of calculating the Management Fee, the Gross Asset Value is determined by the Company’s board of directors (including any committee thereof). Until August 6, 2019, the Management Fee for each quarter was calculated based on the Company’s average Gross Asset Value at the end of each month during such calendar quarter (prior to taking into account any Incentive Fee); provided, that the Management Fee for the Company’s first calendar quarter was calculated based on the Company’s Gross Asset Value at the end of such calendar quarter (prior to taking into account any Incentive Fee). Following August 6, 2019, the Management Fee for each quarter is calculated based on the Company’s average Gross Asset Value at the end of such quarter and at the end of the preceding quarter (in each case, prior to taking into account any Incentive Fee); provided, that the Management Fee for the calendar quarter in which the Company consummates a Qualified Listing will be calculated based on the Company’s Gross Asset Value at the end of such calendar quarter (prior to taking into account any Incentive Fee). For the three and six months ended March 31, 2020, base management fees were $866,511 and $1,652,645, respectively. For the three and six months ended March 31, 2019, base management fees were $332,290 and $453,219, respectively.

The term “Gross Asset Value” means the value of the Company’s gross assets, determined on a consolidated basis in accordance with GAAP, including portfolio investments purchased with borrowed funds and other forms of leverage, but excluding cash and cash equivalents.

The term “Unleveraged Asset Value” means the Gross Asset Value less the Company’s borrowings for investment purposes determined on a consolidated basis in accordance with GAAP (other than borrowings under the Company’s investor subscription credit facility that are repaid within 180 days following incurrence).

38

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Incentive Fee

The Incentive Fee consists of two parts: the Investment Income Incentive Fee and the Capital Gains Incentive Fee (each defined below).

Investment Income Incentive Fee

The Investment Income Incentive Fee is calculated and payable quarterly in arrears based on the Company’s Pre-Incentive Fee Net Investment Income, which means consolidated interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during the calendar quarter, minus the operating expenses accrued for the quarter (including the Management Fee, Company expenses and any interest expense or fees on any credit facilities or outstanding debt, but excluding the Incentive Fee). The Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that has not yet been received in cash. For the avoidance of doubt, the Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The Pre-Incentive Fee Net Investment Income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to a hurdle of 1.50% per quarter (6% annualized) (the “Hurdle Rate”). The Company pays the Adviser an Investment Income Incentive Fee each quarter as follows:

(a) Hurdle Rate Return: No Investment Income Incentive Fee in any calendar quarter in which the Pre-Incentive Fee Net Investment Income does not exceed the Hurdle Rate;

(b) Catch-Up: 100% of the Pre-Incentive Fee Net Investment Income, if any, that exceeds the Hurdle Rate but is less than a 1.875% (7.5% annualized) rate of return on the value of the Company’s net assets in such calendar quarter (the “Catch-Up”), which is intended to provide the Adviser with 20% of the Pre-Incentive Fee Net Investment Income as if the Hurdle Rate did not apply, if the Pre-Incentive Fee Net Investment Income exceeds the Hurdle Rate in such calendar quarter; and

(c) 80/20 Split: 20% of the Pre-Incentive Fee Net Investment Income, if any, that exceeds a 1.875% (7.5% annualized) rate of return on the value of the Company’s net assets in such calendar quarter, so that once the Hurdle Rate is reached and the Catch-Up in (b) immediately above is achieved, 20% of the Pre-Incentive Fee Net Investment Income thereafter is allocated to the Adviser.

The foregoing calculations will be appropriately prorated for any period of less than three months and adjusted for any issuances or repurchases of Common Stock during a quarter. For the three and six months ended March 31, 2020, Investment Income Incentive Fees were $803,813 and $853,728, respectively. For the three and six months ended March 31, 2019, there was no Investment Income Incentive Fee.

Capital Gains Incentive Fee

In addition to the Investment Income Incentive Fee described above, the Adviser is entitled to receive a Capital Gains Incentive Fee (as defined below). The Capital Gains Incentive Fee is determined and payable in arrears as of the end of each calendar year. The Capital Gains Incentive Fee is equal to 20% of the realized capital gains, if any, on a cumulative basis from the date of the Initial Closing through the end of each calendar year, computed net of all realized capital losses on a cumulative basis and unrealized capital depreciation, less the aggregate amount of any previously paid Capital Gains Incentive Fee with respect to each of the investments in the Company’s portfolio, provided that the Capital Gains Incentive Fee determined as of December 31, 2018 was calculated for a period of shorter than 12 calendar months to take into account any realized capital gains computed net of all realized capital losses and unrealized capital depreciation from the date of the Initial Closing through the end of 2018 (the “Capital Gains Incentive Fee,” and together with the Investment Income Incentive Fee, the “Incentive Fee”).

Although the Capital Gains Incentive Fee due to the Adviser is not payable until it is contractually due based on the Investment Advisory Agreement, the Company accrues this component at the end of each reporting period based on the Company’s realized capital gains, if any, on a cumulative basis from the date of the Initial Closing through the end of each reporting period, computed net of all realized capital losses on a cumulative basis and unrealized capital depreciation, less the aggregate amount of any previously paid Capital Gains Incentive Fee, as contractually included in the calculation of the Capital Gains Incentive Fee, plus the cumulative amount of unrealized capital appreciation. If such amount is positive at the end of a period, then the Company will accrue an incentive fee equal

39

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

to 20% of such amount. If such amount is negative, then there will be no accrual for such period or an appropriate reduction in any amount previously accrued. U.S. GAAP requires that the Capital Gains Incentive Fee accrual consider cumulative unrealized capital appreciation in the calculation, as a Capital Gains Incentive Fee would be payable if such unrealized capital appreciation were realized. There can be no assurance that such unrealized capital appreciation will be realized in the future. For the three and six months ended March 31, 2020, the Company reversed $1,104,890 and $427,572 of previously accrued Capital Gains Incentive Fee, respectively. For the three and six months ended March 31, 2019, the Company accrued $350,369 and $308,348 of Capital Gains Incentive Fee, respectively. As of March 31, 2020, there was no Capital Gains Incentive Fee accrued on a cumulative basis. As of March 31, 2020, the Company has not paid any capital gains incentive fees, and no amount is currently payable under the terms of the Investment Advisory Agreement.

As of March 31, 2020 and September 30, 2019, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $1,670,324 and $1,128,658, respectively, reflecting the unpaid portion of the Base Management Fee and Incentive Fee payable to the Adviser.

Administration Agreement

The Company entered into an administration agreement (the “Administration Agreement”) with Oaktree Fund Administration, LLC (the “Administrator”), an affiliate of the Adviser. Pursuant to the Administration Agreement, the Administrator furnishes the Company with office facilities (certain of which are located in buildings owned by a Brookfield affiliate), equipment and clerical, bookkeeping and recordkeeping services at such facilities. Under the Administration Agreement, the Administrator also performs, or oversees the performance of, the Company’s required administrative services, which include, among other things, providing assistance in accounting, legal, compliance, operations, technology and investor relations, and being responsible for the financial records that the Company is required to maintain and preparing reports to stockholders and reports filed with the SEC. In addition, the Administrator assists the Company in determining and publishing the net asset value, overseeing the preparation and filing of tax returns and the printing and dissemination of reports to the Company’s stockholders, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others.

Payments under the Administration Agreement are equal to an amount that reimburses the Administrator for its costs and expenses incurred in performing its obligations under the Administration Agreement and providing personnel and facilities. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other party, by the vote of a majority of the Company’s outstanding voting securities, or by the vote of the Company’s directors or by the Administrator. In addition, our Administrator entered into a sub-administration agreement (the “Sub-Administration Agreement”) with State Street Bank and Trust Company (“State Street”), pursuant to which State Street provides certain administrative and professional services. The Company bears all of the costs and expenses of any sub-administration agreements that the Administrator enters into.

For the avoidance of doubt, the Company bears its allocable portion of the costs of the compensation, benefits, and related administrative expenses (including travel expenses) of the Company’s officers who provide operational and administrative services under the Administration Agreement, their respective staffs and other professionals who provide services to the Company (including, in each case, employees of the Administrator or an affiliate) who assist with the preparation, coordination, and administration of the foregoing or provide other “back office” or “middle office” financial or operational services to the Company. The Company reimburses the Adviser (or its affiliates) for an allocable portion of the compensation paid by the Adviser (or its affiliates) to such individuals (based on a percentage of time such individuals devote, on an estimated basis, to the Company’s business and affairs and to acting on the Company’s behalf). Our board of directors reviews the fees payable under the Administration Agreement to determine that these fees are reasonable and comparable to administrative services charged by unaffiliated third parties.

For the three months ended March 31, 2020, the Company incurred $150,594 of expenses under the Administration Agreement, of which $130,370 was included in administrator expense and the remaining $20,224 was included in general and administrative expenses on the Consolidated Statements of Operations. For the six months ended March 31, 2020, the Company incurred $284,258 of expenses under the Administration Agreement, of which $244,287 was included in administrator expense and the remaining $39,971 was included in general and administrative expenses on the Consolidated Statements of Operations. For the three months ended March 31, 2019, the Company incurred $160,397 of expenses under the Administration Agreement, of which $130,052 was included in administrator expense and the remaining $30,345 was included across general and administrative expenses on the Consolidated Statements of Operations. For the six months ended March 31, 2019, the Company incurred $378,005 of expenses under the Administration Agreement, of which $212,097 was included in administrator expense and the remaining $165,908 was included across general and administrative expenses, offering costs and organization expenses on the Consolidated Statements of Operations. As of March 31, 2020 and September 30, 2019, $295,582 and $753,665, respectively, was included in “Due to affiliates” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses.

40

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Placement Agent Agreement

The Company has entered into a Placement Agent Agreement with OCM Investments, LLC (the “Placement Agent”), an affiliate of the Adviser, which may require investors (other than investors sourced by the Company, the Adviser, the Placement Agent or their respective affiliates) to pay a distribution fee to the Placement Agent for its services. Although the Company does not pay any fees to the Placement Agent, the Company indemnifies the Placement Agent in connection with its activities.

Note 10. Financial Highlights

	Three months ended March 31, 2020			Three months ended March 31, 2019			Six months ended March 31, 2020			Six months ended March 31, 2019
Net asset value at beginning of period	$	20.68		$	19.57		$	20.65		$	19.70
Net investment income (1)	0.51			0.09			0.74			0.19
Net unrealized appreciation (depreciation) (1)(2)	(3.55		)	0.72			(3.18		)	0.39
Net realized gains (losses) (1)	0.04			0.02			0.08			0.03
Distributions to stockholders	(0.31		)	—			(0.92		)	—
Effect of sale price of drawdowns (3)	—			—			—			0.09
Net asset value at end of period	$	17.37		$	20.40		$	17.37		$	20.40
Total return (4)	(14.74		)%	4.24		%	(12.07		)%	3.55		%
Common stock outstanding at beginning of period	8,309,861			3,391,900			8,309,861			1,541,738
Common stock outstanding at end of period	11,575,664			3,391,900			11,575,664			3,391,900
Net assets at beginning of period	$	171,836,163		$	66,395,254		$	171,626,750		$	30,372,317
Net assets at end of period	$	201,013,682		$	69,186,756		$	201,013,682		$	69,186,756
Average net assets (5)	$	157,342,426		$	67,791,005		$	164,877,772		$	60,145,845
Ratio of net investment income to average net assets (6)	2.75		%	0.44		%	3.77		%	0.95		%
Ratio of total expenses to average net assets (6)	1.79		%	2.81		%	3.77		%	4.65		%
Ratio of portfolio turnover to average investments at fair value (6)	15.21		%	3.44		%	27.93		%	6.55		%
Weighted average outstanding debt	$	170,241,758		$	33,322,222		$	144,732,240		$	17,802,198
Average debt per share (1)	$	20.05		$	9.82		$	17.23		$	5.87
Asset coverage ratio (7)	234.01		%	191.04		%	234.01		%	191.04		%

(1)	Calculated based upon weighted average shares outstanding for the period.
(2)	For the three and six months ended March 31, 2020 and 2019, the amount shown does not correspond with net unrealized appreciation (depreciation) for the period as it includes the effect of the timing of equity issuances.
(3)	Increase is due to drawdowns during the period that were executed at a sale price at a premium to net asset value in order to effect a reallocation of organizational costs to subsequent investors.
(4)	Total return is calculated as the change in net asset value (“NAV”) per share during the period, plus distributions per share or capital activity, if any, divided by the beginning NAV per share, assuming a dividend reinvestment price equal to the NAV per share at the beginning of the period. The total return has not been annualized.
(5)	Calculated based upon the weighted average net assets for the period.
(6)	Financial results for the three and six months ended March 31, 2020 and 2019 have not been annualized for purposes of this ratio.
(7)	Based on outstanding senior securities of $150.0 million and $76.0 million as of March 31, 2020 and 2019, respectively.

41

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 11. Commitments and Contingencies

Off-Balance Sheet Arrangements

The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As indicated in the table below, as of March 31, 2020 and September 30, 2019, off-balance sheet arrangements consisted of $19,261,420 and $11,030,903, respectively, of unfunded commitments to provide debt financing to certain of the Company's portfolio companies. Such commitments are subject to the portfolio company's satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.

	March 31, 2020		September 30, 2019
WPEngine, Inc.	$	9,504,950	$	—
Assembled Brands Capital LLC	3,586,452		3,807,021
Corrona, LLC	1,560,000		—
MRI Software LLC	1,035,963		—
PaySimple, Inc.	876,659		2,695,000
Accupac, Inc.	856,511		—
OEConnection LLC	822,511		817,204
Acquia Inc.	468,601		—
Apptio, Inc.	461,538		461,538
iCIMs, Inc.	88,235		88,235
Sorrento Therapeutics, Inc.	—		2,400,000
Mindbody, Inc.	—		761,905
	$	19,261,420	$	11,030,903

Note 12. Derivative Instruments

The Company enters into forward currency contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies.

In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement ("ISDA Master Agreement") with its derivative counterparty, The Bank of New York Mellon. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. No cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.

Net unrealized gains or losses on foreign currency contracts are included in “net unrealized appreciation (depreciation)” and net realized gains or losses on forward currency contracts are included in “net realized gains (losses)” in the accompanying Consolidated Statements of Operations. Forward currency contracts are considered undesignated derivative instruments.

Certain information related to the Company’s foreign currency forward contracts is presented below as of March 31, 2020.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	2,981,267	€	2,662,178	5/14/2020	$	55,258	$	—	Derivative assets

42

OAKTREE STRATEGIC INCOME II, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2019.

Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	2,798,483	€	2,475,000	1/16/2020	$	77,558	$	—	Derivative assets

Note 13. Subsequent Events

The Company's management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of and for the three and six months ended March 31, 2020, except as discussed below.

Distribution Declaration

On May 11, 2020, the Company's board of directors approved a quarterly distribution not to exceed $3.4 million, payable in cash on June 30, 2020 in an amount per share based on the outstanding number of shares held by the Company's stockholders as of the close of business on June 15, 2020.

Capital Drawdown

On April 30, 2020, the Company issued 5,832,194 shares of Common Stock for an aggregate offering price of approximately $101.3 million pursuant to the Subscription Agreement and a capital drawdown notice delivered by the Company to its investors dated April 20, 2020.

Investment Advisory Agreement

On May 11, 2020, the Adviser effected the novation of the Investment Advisory Agreement to Oaktree Fund Advisors, LLC, a registered investment adviser under common control with the Adviser.  Immediately following such novation, the Company and Oaktree Fund Advisors, LLC entered into a new investment advisory agreement with the same terms, including fee structure, as the Investment Advisory Agreement.

43

Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the Consolidated Financial Statements and the notes thereto included elsewhere in this quarterly report on Form 10-Q.

Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:

• our future operating results and distribution projections;

• the ability of our Adviser to implement its future plans with respect to our business and to achieve our investment objective;

• the ability of Oaktree to attract and retain highly talented professionals;

• our business prospects and the prospects of our portfolio companies;

• the impact of the investments that we expect to make;

• the ability of our portfolio companies to achieve their objectives;

• our expected financings and investments and additional leverage we may seek to incur in the future;

• the adequacy of our cash resources and working capital;

• the timing of cash flows, if any, from the operations of our portfolio companies; and

• the impact of the COVID-19 pandemic on all of the foregoing.

In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended September 30, 2019 and elsewhere in this quarterly report on Form 10-Q.

Other factors that could cause actual results to differ materially include:

• changes or potential disruptions in our operations, the economy, financial markets or political environment;

• risks associated with possible disruption in our operations, the operations of our portfolio companies or the economy generally due to terrorism, natural disasters or the COVID-19 pandemic;

• future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to Business Development Companies or regulated investment companies ("RICs");

• general considerations associated with the COVID-19 pandemic; and

• other considerations that may be disclosed from time to time in our publicly disseminated documents and filings.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

Business Overview

We are structured as a closed-end investment company focused on lending to small-and medium-sized companies. We have elected to be regulated as a BDC under the Investment Company Act and have elected to be treated, and intend to comply with the requirements to qualify annually, as a RIC under Subchapter M of the Code.

We were formed on April 30, 2018 as a Delaware corporation and are externally managed by our Adviser. We seek to invest opportunistically across asset classes and geographies, primarily in the form of senior loans, and to a lesser extent, high yield bonds, to borrowers that are in need of direct loans, rescue financings or other capital solutions or that have had challenged or unsuccessful primary offerings. Our investment objective is to generate current income and long-term capital appreciation. We seek to achieve our investment objective without subjecting principal to undue risk of loss by investing primarily in situations where a company or its owners (a) are overleveraged or facing pressures to recapitalize, (b) are unable to access broadly syndicated capital markets, (c) are undervalued after having recently exited bankruptcy or completed a restructuring or (d) are otherwise affected by mispricings or inefficiencies in the capital markets or at different points throughout the credit cycle. We seek to generate revenues primarily in the form of interest income from the investments we hold.

We conduct Private Offerings of shares of our Common Stock to investors in reliance on exemptions from the registration requirements of the Securities Act. At each Closing of a Private Offering, each investor participating in that closing makes a Capital

44

Commitment to purchase our Common Stock pursuant to a Subscription Agreement entered into with us in connection with its Capital Commitment. Investors are required to fund drawdowns to purchase our Common Stock up to the amount of their respective Capital Commitments on an as-needed basis with a minimum of ten calendar days' prior notice (excluding the initial drawdown for each investor). The Initial Closing occurred on August 6, 2018. Loan origination and investment activities commenced shortly after the Initial Closing. As of March 31, 2020, we received $337,683,996 in Capital Commitments from investors in connection with Private Offerings.

We commenced our loan origination and investment activities shortly after the Initial Closing. The proceeds from the Initial Closing provided us with the necessary seed capital to commence operations. As of March 31, 2020, we completed drawdowns of $236,378,797, or 70.0%, on Capital Commitments. As of March 31, 2020, we held $354,696,821 of investments at fair value, up from $291,147,011 held at September 30, 2019, primarily driven by additional borrowings under our credit facilities and drawdowns on capital commitments, partially offset by unrealized depreciation on our investment portfolio largely due to increased market volatility and wider credit spreads resulting from the onset of the COVID-19 pandemic in March 2020 and the direct impact of the COVID-19 pandemic on certain of our portfolio companies.

Business Environment and Developments

We believe that the COVID-19 pandemic has contributed to significant market volatility and disruption, which may have lasting effects on the U.S. and global financial markets and has caused (and may cause further) economic uncertainties or deterioration in the performance of middle market companies in the United States and worldwide.

In particular, the disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets, significant write-offs in the financial sector and re-pricing of credit risk in the broadly syndicated market. This widening of spreads makes it more difficult for middle market businesses to access capital as lenders could become more selective in evaluating investment opportunities, equity sponsors delay transactions given earnings uncertainty and sellers are hesitant to accept lower purchase price multiples.

In this type of environment, we believe attractive risk-adjusted returns can be achieved by making loans to companies in the middle market. Given the breadth of Oaktree’s investment platform, we believe that we have the resources and experience to source, diligence and structure investments in these companies and are well placed to generate attractive returns for investors.

We have proactively taken a number of actions to evaluate and support our portfolio companies in light of the COVID-19 pandemic, including outreach to a variety of management teams and sponsors.  We have established a dialogue with many of our portfolio companies and are especially focused on those portfolio companies that may be subject to a moderate to high risk of material impacts from COVID-19. We believe that these efforts to identify vulnerable portfolio companies will allow us to address potential problems early and provide constructive solutions.

As of March 31, 2020, 94.9% of our debt investment portfolio (at fair value) and 95.1% of our debt investment portfolio (at cost) bore interest at floating rates indexed to the London Interbank Offered Rate ("LIBOR"), and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly or monthly at the borrower’s option. As a result of the COVID-19 pandemic and the related decision of the U.S. Federal Reserve to reduce certain interest rates, LIBOR decreased in March 2020. A prolonged reduction in interest rates will result in a decrease in our total investment income and could result in a decrease in our net investment income to the extent the decreases are not offset by an increase in the spread on our floating rate investments, a decrease in our interest expense or a reduction of our incentive fee on income. In July 2017, the head of the United Kingdom Financial Conduct Authority announced the desire to phase out the use of LIBOR by the end of 2021. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, is considering replacing U.S.-dollar LIBOR with the Secured Overnight Financing Rate ("SOFR"), a new index calculated by short-term repurchase agreements, backed by Treasury securities. Although there have been a few transactions utilizing SOFR or the Sterling Over Night Index Average, an alternative reference rate that is based on transactions, it remains unknown whether these alternative reference rates will attain market acceptance as replacements for LIBOR. If LIBOR ceases to exist, we may need to renegotiate any credit agreements extending beyond 2021 with our prospective portfolio companies that utilize LIBOR as a factor in determining the interest rate and may also need to renegotiate the terms of our borrowing facilities. Certain of the loan agreements with our portfolio companies have included fallback language in the event that LIBOR becomes unavailable. This language generally provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. Certain of the loan agreements with our portfolio companies do not include any fallback language providing a mechanism for the parties to negotiate a new reference interest rate and will instead revert to the base rate in the event LIBOR ceases to exist. It remains unclear whether the cessation of LIBOR will be delayed due to COVID-19 or what form any delay may take, and there are no assurances that there will be a delay. It is also unclear what the duration and severity of COVID-19 will be, and whether this will impact LIBOR transition planning. COVID-19 may also slow regulators’ and others’ efforts to develop and implement alternative reference rates, which could make LIBOR transition planning more difficult, particularly if the cessation of LIBOR is not delayed and alternatives do not develop.

45

Critical Accounting Policies

Basis of Presentation

Our accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the consolidated financial statements have been made. All intercompany balances and transactions have been eliminated in consolidation. We are an investment company following the accounting and reporting guidance in Financial Accounting Standards Board ("FASB"), Accounting Standards Codification ("ASC"), Topic 946, Financial Services – Investment Companies, or ASC 946.

Fair Value Measurements

Our board of directors, with the assistance of our audit committee (the “Audit Committee”) and the Adviser, determines the fair value of our assets on at least a quarterly basis, in accordance with the terms of FASB ASC Topic 820, Fair Value Measurement. The Audit Committee is comprised of independent directors. Our investments are valued at fair value. For purposes of periodic reporting, the Company values its assets in accordance with GAAP and based on the principles and methods of valuation summarized below. GAAP requires that a “fair value” be assigned to all assets and establishes a single authoritative definition of fair value that includes a framework for measuring fair value and enhanced disclosures about fair value measurements.

GAAP establishes a hierarchal disclosure framework, which prioritizes the inputs used in measuring financial instruments at fair value into three levels based on their market price observability. Market price observability is affected by a number of factors, including the type of instrument and the characteristics specific to the instrument. Financial instruments with readily available quoted prices from an active market or for which fair value can be measured based on actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value.

Financial assets and liabilities measured and reported at fair value are classified as follows:

• Level I - Quoted unadjusted prices for identical instruments in active markets to which we have access at the date of measurement. The types of investments in Level I include exchange traded equities, debt and derivatives with quoted prices.

• Level II - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are directly or indirectly observable. Level II inputs include interest rates, yield curves, volatilities, prepayment risks, loss severities, credit risks and default rates. The types of investments in Level II generally include corporate bonds and loans, government and agency securities, less liquid and restricted equity investments, over-the-counter traded derivatives and other investments where the fair value is based on observable inputs.

• Level III - Valuations for which one or more significant inputs are unobservable. These inputs reflect our assessment of the assumptions that market participants use to value the investment based on the best available information. Level III inputs include prices obtained from brokers in markets for which there are few transactions, less public information exists or prices vary among broker market makers. The types of investments in Level III include non-publicly traded equity, debt, real estate and derivatives.

In some instances, an instrument may fall into different levels of the fair value hierarchy. In such instances, the instrument’s level within the fair value hierarchy is based on the lowest of the three levels (with Level III being the lowest) that is significant to the value measurement. The assessment of the significance of an input requires judgment and considers factors specific to the instrument. The transfer of assets into or out of each fair value hierarchy level as a result of changes in the observability of the inputs used in measuring fair value are accounted for as of the beginning of the reporting period. Transfers resulting from a specific event, such as a reorganization or restructuring, are accounted for as of the date of the event that caused the transfer.

In the absence of observable market prices, we value Level III investments using valuation methodologies applied on a consistent basis. The quarterly valuation process for Level III investments begins with each portfolio company, property or security being initially valued by the Adviser's valuation team in conjunction with the investment team. The preliminary valuations are then reviewed and approved by the valuation team, the valuation committee, which consists of senior members of the investment team, and designated investment professionals as well as the valuation officer who is independent of the investment teams. The Audit Committee reviews the preliminary valuations provided by the valuation committee and makes a recommendation to our full board of directors regarding the fair value of the investments in our portfolio. Our board of directors ultimately determines in good faith the fair value of each investment in our portfolio. Results of the valuation process are evaluated each quarter, including an assessment of whether the underlying calculations should be adjusted or recalibrated. In connection with this process, we evaluate changes in fair value measurements from

46

period to period for reasonableness, considering items such as industry trends, general economic and market conditions, and factors specific to the investment.

Certain Level III assets are valued using prices obtained from pricing vendors or brokers. These investments are classified as Level III because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustment for investment-specific factors or restrictions. We seek to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If we are unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within our set threshold, we seek to obtain a quote directly from a broker making a market for the asset. However, given the nature of our portfolio, we do not expect that all of our Level III assets will be valued at least annually using prices obtained from pricing vendors or brokers. Generally, we do not adjust any of the prices received from these sources, and all prices are reviewed by us. We evaluate the prices obtained from pricing vendors or brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. The Adviser also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, the Adviser performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process.

Non-publicly traded debt and equity securities and other securities or instruments for which reliable market quotations are not available are valued by us using valuation methodologies applied on a consistent basis. These securities may initially be valued at the acquisition price as the best indicator of fair value. We review the significant unobservable inputs, valuations of comparable investments and other similar transactions for investments valued at acquisition price to determine whether another valuation methodology should be utilized. Subsequent valuations will depend on facts and circumstances known as of the valuation date and the application of valuation methodologies further described below under “–Non-Exchange-Traded Investments.” The fair value may also be based on a pending transaction expected to close after the valuation date. These valuation methodologies involve a significant degree of management judgment. Accordingly, valuations do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments in the future. Fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to the consolidated financial statements.

Exchange-Traded Investments

Securities listed on one or more national securities exchanges are valued at their last reported sales price on the date of valuation. If no sale occurred on the valuation date, the security is valued at the mean of the last “bid” and “ask” prices on the valuation date. Securities that are not marketable due to legal restrictions that may limit or restrict transferability are generally valued at a discount from quoted market prices. The discount would reflect the amount market participants would require due to the risk relating to the inability to access a public market for the security for the specified period and would vary depending on the nature and duration of the restriction and the risk and volatility of the underlying securities. Securities with longer duration restrictions or higher volatility are generally valued at a higher discount. Such discounts are generally estimated based on put option models or analysis of market studies. Instances where discounts have been applied to quoted prices of restricted listed securities have been infrequent. The impact of such discounts is not material to the consolidated financial statements.

Non-Exchange-Traded Investments

Investments in corporate and government debt which are not listed or admitted to trading on any securities exchange are valued at the mean of the last bid and ask prices on the valuation date based on quotations supplied by recognized quotation services or by reputable broker dealers.

If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, we value such investments using different valuation techniques. One valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The market yield technique is considered in the valuation of non-publicly traded debt investments, utilizing expected future cash flows, discounted using estimated current market rates. Discounted cash flow calculations may be adjusted to reflect current market conditions and/or the perceived credit risk of the borrowers. Consideration is also given to a borrower’s ability to meet principal and interest obligations; this may include an evaluation of collateral or the underlying value of the borrower, utilizing either the market or income techniques. A market technique utilizes valuations of comparable public companies or transactions and generally seeks to establish the enterprise value of the portfolio company using a market multiple technique. This technique takes into account a specific financial measure (such as earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA, free cash flow, net operating income, net income, book value or net asset value) believed to be most relevant for the given company. Consideration may also be given to such factors as acquisition price of the security, historical and projected operational and financial results for the portfolio company, the strengths and weaknesses of the portfolio company relative to its comparable companies, industry trends, general economic and market conditions and other factors deemed relevant. The income technique is typically a discounted cash flow method that incorporates expected timing and level of cash flows. It incorporates assumptions in determining growth rates, income and expense projections, discount rates, capital structure, terminal values and other factors. The applicability and weight assigned to market and income techniques are determined based on the availability of reliable projections and comparable companies and transactions.

47

The valuation of securities may be impacted by expectations of investors’ receptiveness to a public offering of the securities, the size of the holding of the securities and any associated control, information with respect to transactions or offers for the securities (including the transaction pursuant to which the investment was made and the period of time elapsed from the date of the investment to the valuation date) and applicable restrictions on the transferability of the securities.

Investments made by us are, by nature, generally considered to be long-term investments and are not intended to be liquidated on a short-term basis. Additionally, these valuation methodologies involve a significant degree of management judgment. Accordingly, valuations by us do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments in the future. Estimated fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to the consolidated financial statements.

We may estimate the fair value of privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an enterprise value analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk-free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.

With the exception of the line items entitled "deferred financing costs," "other assets," and "credit facilities payable," which are reported at amortized cost, all assets and liabilities on the Consolidated Statements of Assets and Liabilities approximate fair value. The carrying value of the line items titled "interest receivable," "receivables from unsettled transactions," "receivable for shares sold," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliates," "interest payable," "deferred tax liability" and "payables from unsettled transactions" approximate fair value due to their short maturities.

Revenue Recognition

We generate revenues in the form of interest income on debt investments and, to a lesser extent, capital gains and distributions, if any, on equity securities that we may acquire in portfolio companies. Some of our investments provide for deferred interest payments or payment-in-kind ("PIK") interest. The principal amount of the debt investments and any accrued but unpaid interest generally becomes due at the maturity date.

Interest Income

Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. During the three months ended March 31, 2020, with the exception of one portfolio company that modified its scheduled interest payment to PIK in order to preserve liquidity, all of our portfolio companies made their scheduled interest payments. As of March 31, 2020, there were no investments on which we had stopped accruing cash interest and/or PIK interest or OID income.

In connection with our investment in a portfolio company, we sometimes receive nominal cost equity that is valued as part of the negotiation process with the portfolio company. When we receive nominal cost equity, we allocate our cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.

Fee Income

The Adviser may provide financial advisory services to portfolio companies in connection with structuring a transaction and in return we may receive fees for capital structuring services. These fees are generally nonrecurring and are recognized by us upon the investment closing date. We may also receive additional fees in the ordinary course of business, including servicing, amendment, and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered.

We have also structured exit fees across certain of our portfolio investments to be received upon the future exit of those investments. Exit fees are payable upon the exit of a debt security. These fees are to be paid to us upon the sooner to occur of (i) a sale of the borrower or substantially all of the assets of the borrower, (ii) the maturity date of the loan or (iii) the date when full prepayment of the loan occurs. The receipt of such fees is contingent upon the occurrence of one of the events listed above for each of the investments. These fees are included in net investment income over the life of the loan.

PIK Interest Income

Our investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We generally cease accruing PIK interest if there is insufficient value to support the

48

accrual or if we do not expect the portfolio company to be able to pay all principal and interest due. Our decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; our assessment of the portfolio company's business development success; information obtained by us in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. Our determination to cease accruing PIK interest is generally made well before our full write-down of a loan or debt security. In addition, if it is subsequently determined that we will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on our debt investments increases the recorded cost bases of these investments in our consolidated financial statements including for purposes of computing the capital gains incentive fee payable by us to the Adviser. To maintain our status as a RIC, certain income from PIK interest may be required to be distributed to our stockholders even though we have not yet collected the cash and may never do so.

Portfolio Composition

As of March 31, 2020, the fair value of our investment portfolio was $354.7 million and was comprised of investments in 107 portfolio companies. As of September 30, 2019, the fair value of our investment portfolio was $291.1 million and was comprised of investments in 69 portfolio companies.

As of March 31, 2020 and September 30, 2019, our investment portfolio consisted of the following:

	March 31, 2020		September 30, 2019
Cost:
Senior secured debt	$	372,648,045	$	281,238,755
Subordinated debt	16,393,453		7,201,102
Common equity & warrants	1,043,713		772,692
Preferred equity	110,285		110,285
Total	$	390,195,496	$	289,322,834

	March 31, 2020		September 30, 2019
Fair Value:
Senior secured debt	$	338,700,828	$	282,841,206
Subordinated debt	14,717,002		7,325,965
Common equity & warrants	1,165,398		869,555
Preferred equity	113,593		110,285
Total	$	354,696,821	$	291,147,011

49

The table below describes investments by industry composition based on fair value as a percentage of total investments:

	March 31, 2020		September 30, 2019
Fair Value:
Application Software	20.18	%	20.64	%
Personal Products	6.14	%	1.73	%
Integrated Telecommunication Services	4.51	%	6.38	%
Health Care Technology	4.45	%	4.27	%
Biotechnology	4.39	%	7.14	%
Internet Services & Infrastructure	4.11	%	6.52	%
Alternative Carriers	3.70	%	3.22	%
Oil & Gas Storage & Transportation	3.66	%	—	%
Health Care Services	3.27	%	3.78	%
Systems Software	2.96	%	4.51	%
Pharmaceuticals	2.74	%	2.90	%
Data Processing & Outsourced Services	2.56	%	2.80	%
Specialized REITs	2.22	%	1.15	%
Independent Power Producers & Energy Traders	2.20	%	—	%
Real Estate Services	2.20	%	3.05	%
Diversified Support Services	2.15	%	3.22	%
Distributors	2.00	%	—	%
Airport Services	1.99	%	—	%
Oil & Gas Refining & Marketing	1.98	%	2.75	%
Aerospace & Defense	1.96	%	2.40	%
Publishing	1.96	%	0.68	%
Research & Consulting Services	1.68	%	2.74	%
Movies & Entertainment	1.64	%	1.20	%
Metal & Glass Containers	1.46	%	0.48	%
Health Care Supplies	1.44	%	—	%
Auto Parts & Equipment	1.39	%	2.00	%
Industrial Machinery	1.31	%	0.47	%
IT Consulting & Other Services	1.31	%	1.83	%
Multi-Sector Holdings	1.01	%	—	%
Interactive Media & Services	1.00	%	2.31	%
Construction Materials	0.99	%	—	%
Managed Health Care	0.97	%	1.37	%
Trading Companies & Distributors	0.72	%	1.03	%
Communications Equipment	0.67	%	—	%
Household Products	0.51	%	0.65	%
Restaurants	0.50	%	—	%
Property & Casualty Insurance	0.37	%	—	%
Cable & Satellite	0.32	%	1.46	%
Specialized Finance	0.25	%	0.27	%
Environmental & Facilities Services	0.24	%	—	%
Building Products	0.16	%	—	%
Specialty Stores	0.16	%	—	%
Food Retail	0.13	%	0.34	%
Construction & Engineering	0.12	%	0.34	%
Leisure Facilities	0.09	%	—	%
Oil & Gas Equipment & Services	0.08	%	0.30	%
Casinos & Gaming	0.08	%	—	%
Health Care Facilities	0.07	%	—	%
Financial Exchanges & Data	—	%	1.95	%
Health Care Equipment	—	%	1.72	%
Insurance Brokers	—	%	1.35	%
Electric Utilities	—	%	0.42	%
Health Care Distributors	—	%	0.39	%
Oil & Gas Exploration & Production	—	%	0.24	%
Total	100.00	%	100.00	%

50

The table below describes investments by geographic composition at fair value as a percentage of total investments:

	March 31, 2020		September 30, 2019
Fair Value:
United States	87.58	%	89.06	%
United Kingdom	4.58	%	3.81	%
Luxembourg	2.31	%	2.64	%
France	1.94	%	1.81	%
Iceland	1.39	%	1.61	%
Australia	1.32	%	—	%
Canada	0.88	%	0.99	%
Denmark	—	%	0.08	%
Total	100.00	%	100.00	%

See the Schedule of Investments as of March 31, 2020 and September 30, 2019 in our consolidated financial statements in Part I, Item 1, of this Form 10-Q for more information on these investments, including a list of companies and the type, cost and fair value of investments.

 Discussion and Analysis of Results and Operations

Results of Operations

The principal measure of our financial performance is the net increase (decrease) in net assets resulting from operations, which includes net investment income (loss), net realized gains (losses) and net unrealized appreciation (depreciation). Net investment income (loss) is the difference between our income from interest income and fee income and excise taxes and total expenses. Net realized gains (losses) on investments is the difference between the proceeds received from dispositions of portfolio investments and their stated costs. Net unrealized appreciation (depreciation) is the net change in the fair value of our investment portfolio during the reporting period, including the reversal of previously recorded unrealized appreciation (depreciation) when gains or losses are realized. The net increase or decrease in net assets from operations may vary substantially from period to period as a result of various factors, including the recognition of realized gains and losses and net change in unrealized appreciation and depreciation.

Comparison of the three and six months ended March 31, 2020 and March 31, 2019

Investment Income

Total investment income for the three months ended March 31, 2020 was $7,136,328 and consisted of $6,688,961 of interest income primarily from portfolio investments (including $374,393 of PIK interest income) and $447,367 of fee income. Total investment income for the three months ended March 31, 2019 was $2,199,688 and consisted of $2,190,574 of interest income primarily from portfolio investments (including $191,748 of PIK interest income) and $9,114 of fee income. The increase in total investment income was primarily due to an increase in the size of our investment portfolio as compared to the prior year comparable quarter.

Total investment income for the six months ended March 31, 2020 was $12,430,906 and consisted of $11,853,592 of interest income primarily from portfolio investments (including $525,625 of PIK interest income) and $577,314 of fee income. Total investment income for the six months ended March 31, 2019 was $3,365,906 and consisted of $3,101,228 of interest income primarily from portfolio investments (including $259,694 of PIK interest income) and $264,678 of fee income. The increase in total investment income was primarily due to an increase in the size of our investment portfolio as compared to the prior year comparable period. Based on fair value as of March 31, 2020, the weighted average yield on our debt investments was 6.6%, compared to 7.6% as of March 31, 2019.

51

Expenses

Total expenses for the three months ended March 31, 2020 and March 31, 2019 were $2,816,186 and $1,903,545, respectively. The increase in total expenses was primarily due to (1) an increase in the size of our investment portfolio as compared to the prior year quarter, which drove a $534,221 increase in base management fees and an increase in borrowings, which contributed to a $1,178,704 increase in interest expense, and (2) an increase in total investment income which resulted in a $803,813 increase in investment income incentive fee, partially offset by a $1,455,259 decrease in capital gains incentive fees, which was driven by a $1,104,890 reversal of previously accrued capital gains incentive fees as a result of unrealized depreciation on investments during the quarter, largely due to increased market volatility and wider credit spreads resulting from the onset of the COVID-19 pandemic in March 2020 and the direct impact of the COVID-19 pandemic on certain of our portfolio companies.

Total expenses for the six months ended March 31, 2020 and March 31, 2019 were $6,213,679 and $2,785,883, respectively. The increase in total expenses was primarily due to (1) an increase in the size of our investment portfolio as compared to the prior year quarter, which drove a $1,199,426 increase in base management fees and an increase in borrowings, which contributed to a $2,400,014 increase in interest expense, and (2) an increase in total investment income which resulted in a $853,728 increase in investment income incentive fee, partially offset by a $735,920 decrease in capital gains incentive fees, which was driven by a $427,572 reversal of previously accrued capital gains incentive fees as a result of unrealized depreciation on investments during the quarter, largely due to

increased market volatility and wider credit spreads resulting from the onset of the COVID-19 pandemic in March 2020 and the direct

impact of the COVID-19 pandemic on certain of our portfolio companies.

	Three months ended March 31, 2020			Three months ended March 31, 2019		Six months ended March 31, 2020			Six months ended March 31, 2019
Expenses:
Base management fee	866,511			$	332,290	$	1,652,645		$	453,219
Investment income incentive fee	803,813			—		853,728			—
Capital gains incentive fee	(1,104,890		)	350,369		(427,572		)	308,348
Offering costs	—			194,104		—			362,373
Organization expenses	—			710		—			56,921
Professional fees	253,793			190,929		421,776			383,769
Directors fees	38,750			26,250		77,637			52,500
Interest expense	1,631,976			453,272		2,987,169			587,155
Administrator expense	130,370			130,052		244,287			212,097
General and administrative expenses	195,863			225,569		404,009			369,501
Total expenses	$	2,816,186		$	1,903,545	$	6,213,679		$	2,785,883

Net Unrealized Appreciation (Depreciation)

Net unrealized depreciation was $40,410,913 for the three months ended March 31, 2020, largely due to increased market volatility and wider credit spreads resulting from the onset of the COVID-19 pandemic in March 2020 and the direct impact of the COVID-19 pandemic on certain of our portfolio companies. Net unrealized appreciation on investments was $2,412,574 for the three months ended March 31, 2019 and was primarily driven by volatility experienced in the broadly syndicated loan market and unrealized appreciation from our investment in Sorrento Therapeutics, Inc. during the period.

Net unrealized depreciation was $37,348,382 for the six months ended March 31, 2020, largely due to increased market volatility and wider credit spreads resulting from the onset of the COVID-19 pandemic in March 2020 and the direct impact of the COVID-19 pandemic on certain of our portfolio companies. Net unrealized appreciation on investments was $1,449,489 for the six months ended March 31, 2019 and was primarily driven by unrealized appreciation from our investment in Sorrento Therapeutics, Inc. during the period.

Net Realized Gains (Losses)

Net realized gains were $307,858 and $82,785 for the three months ended March 31, 2020 and 2019, respectively, primarily driven by realized gains resulting from exits of various investments in the portfolio. Net realized gains were $631,915 and $92,254 for the six months ended March 31, 2020 and 2019, respectively, primarily driven by realized gains resulting from exits of various investments in the portfolio.

52

Financial Condition, Liquidity and Capital Resources

We generate cash from (1) the cash proceeds from Private Offerings and any other future offerings of securities, (2) cash flows from operations, including earnings on investments, as well as interest earned from the temporary investment of cash in cash-equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less, and (3) borrowings from banks and issuances of senior securities, including before we have fully invested the cash proceeds of the Private Offerings.

Our primary use of cash is for (1) investments in portfolio companies and other investments to comply with certain portfolio diversification requirements, (2) the cost of operations (including our expenses, the Management Fee and the Incentive Fee), (3) debt service of borrowings under our credit facilities, and (4) cash distributions to the stockholders.

For the six months ended March 31, 2020, we experienced a net increase in cash and cash equivalents of $23,457,185. During that period, $101,367,844 of cash was used in operating activities, primarily consisting of cash used to fund new investments, partially offset by cash proceeds from the sales and repayments of investments. During the same period, cash provided by financing activities was $124,824,982, primarily consisting of $67,000,000 of net borrowings under our credit facilities and $65,472,299 of net proceeds from Private Offerings, partially offset by distributions to stockholders of $7,645,072.

For the six months ended March 31, 2019, we experienced a net decrease in cash and cash equivalents of $2,955,575. During that period, $115,091,497 of cash was used in operating activities, primarily consisting of cash used to fund new investments. During the same period, cash provided by financing activities was $112,090,633, primarily consisting of $36,742,030 of net proceeds from Private Offerings and $76,000,000 of borrowings under our credit facility.

As of March 31, 2020, we had $34,805,311 of cash and cash equivalents (including $2,247,126 of restricted cash), portfolio investments (at fair value) of $354,696,821, $1,044,637 of interest receivable, $2,412,000 of receivable for shares sold, $101,305,199 of remaining capital commitments, $150,000,000 of borrowings outstanding under our credit facilities, $39,351,790 of net payables from unsettled transactions and unfunded commitments of $19,261,420.

As of September 30, 2019, we had $11,348,126 of cash and cash equivalents (including $269,111 of restricted cash), portfolio investments (at fair value) of $291,147,011, $1,005,398 of interest receivable, $347,500 of receivable for shares sold, $83,000,000 of borrowings outstanding under our credit facilities, $47,048,497 of net payables from unsettled transactions and unfunded commitments of $11,030,903.

Equity Activity

As of March 31, 2020, we received $337,683,996 in Capital Commitments from investors in connection with Private Offerings, of which $3,854,346 in Capital Commitments were made by one or more affiliates of the Adviser. As of March 31, 2020, we completed drawdowns of $236,378,797, or 70.0%, of such Capital Commitments.

We have the authority under our organizational documents to issue 250,000,000 shares of Common Stock, $0.001 per share par value and 100,000,000 shares of preferred stock, $0.001 per share par value. The following table summarizes total shares issued and proceeds related to capital drawdowns delivered pursuant to the Subscription Agreements for our Common Stock through March 31, 2020:

	Shares Issued	Price per Share		Proceeds
August 6, 2018 (1)	770,869	$	20.00	$	15,417,385
September 17, 2018	770,869	20.00		15,417,384
October 29, 2018	1,060,964	19.85		21,060,130
November 15, 2018	789,198	19.82		15,641,900
April 29, 2019	1,655,314	20.40		33,768,400
August 30, 2019	1,631,324	20.70		33,768,400
September 23, 2019	1,631,323	20.70		33,768,399
March 26, 2020	3,265,803	20.68		67,536,799
Total	11,575,664			$	236,378,797

__________________

(1) Includes 50 shares issued to one or more affiliates of the Adviser on July 23, 2018.

Leverage

On July 9, 2018, our sole stockholder approved our becoming subject to a minimum asset coverage ratio of 150% as set forth in Section 61(a)(2) of the Investment Company Act. As a result of this approval, we are permitted to borrow amounts so long as our asset coverage ratio, as defined in the Investment Company Act, is at least 150% after such borrowing (if certain requirements are met). As of

53

March 31, 2020, our asset coverage ratio, as defined in the Investment Company Act, was 234.0%, and aggregate outstanding principal amount of indebtedness was $150 million.

We may issue debt securities or preferred stock and/or borrow additional money from banks or other financial institutions, which we refer to collectively as "senior securities," up to the maximum amount permitted by the Investment Company Act. We have securitized and may in the future securitize a portion of our investments to the extent permitted by applicable law and regulation. To securitize investments, we typically create a wholly-owned subsidiary and contribute a pool of loans to the subsidiary. We then typically sell interests in the subsidiary on a non-recourse basis to purchasers and we would retain all or a portion of the equity in the subsidiary. Our primary uses of funds are investments in our targeted asset classes and cash distributions to holders of our common stock.

CNB Facility

On October 16, 2018, we entered into the Credit Agreement between us, as borrower, and City National Bank ("CNB"), as lender. As of March 31, 2020, the Credit Agreement provided for a senior secured revolving credit facility (the "CNB Facility"), of up to $60 million (the "Maximum Commitment"), in aggregate principal amount, subject to (i) the lesser of a percentage of unfunded commitments from certain classes of eligible investors in the Company and (ii) the Maximum Commitment and had a scheduled maturity date of October 15, 2020. On May 1, 2020, we repaid all borrowings outstanding under the CNB Facility, following which the CNB Facility was terminated.

Borrowings under the CNB Facility bore interest at a rate equal to (a) the LIBOR for the selected period plus 1.65% for LIBOR loans or (b) the prime rate of CNB minus 0.25% for prime rate loans. There was a non-usage fee of 25 basis points per year on the unused portion of the CNB Facility, payable quarterly.

The CNB Facility was secured by a first priority security interest, subject to customary exceptions, in (i) all Capital Commitments, (ii) our right to make capital calls, receive payment of capital contributions from investors and enforce payment of capital commitments and capital contributions under our Subscription Agreements with investors and other operative documents and (iii) a cash collateral account into which the capital contributions from investors are made. We have made customary representations and warranties and are required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities. Our borrowings, including under the CNB Facility, were subject to the leverage restrictions contained in the Investment Company Act.

As of March 31, 2020 and September 30, 2019, we had $55.0 million and $65.0 million outstanding under the CNB Facility, respectively. Our borrowings under the CNB Facility bore interest at a weighted average interest rate of 3.46% and 4.20% for the six months ended March 31, 2020 and 2019, respectively. For the three and six months ended March 31, 2020, we recorded interest expense (inclusive of fees) of $813,287 and $1,603,860 related to the CNB Facility, respectively. For the three and six months ended March 31, 2019, the Company recorded interest expense (inclusive of fees) of $453,272 and $587,155, respectively, related to the Credit Facility.

Citibank Facility

On July 26, 2019 (the "Closing Date"), we and OSI 2 Senior Lending SPV, LLC ("OSI 2 SPV"), a wholly-owned and consolidated subsidiary of us, entered into a loan and security agreement (the "Loan Agreement"), with the lenders from time to time party thereto and the other parties referenced below. Under the terms of the Loan Agreement, we serve as the collateral manager and seller and OSI 2 SPV serves as borrower with Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

The Loan Agreement provides for a senior secured revolving credit facility (the "Citibank Facility"), of up to $100 million (the "Maximum Commitment"), in aggregate principal amount, subject to the lesser of (i) the borrowing base, which is an amount based on advance rates that vary depending on the class of assets and the value assigned to such assets under the Loan Agreement and (ii) the Maximum Commitment. The Citibank Facility has a three year reinvestment period (the "Reinvestment Period"), during which advances may be made; and matures five years from the Closing Date. Following the Reinvestment Period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender under the Loan Agreement, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) the LIBOR for a three month maturity and (b) for all other lenders under the Citibank Facility, LIBOR, plus, in each case, an applicable spread. During the Reinvestment Period, the applicable spread is the greater of (i) a weighted average rate of (x) 1.65% per year for broadly syndicated loans and (y) 2.25% per year for all other eligible loans and (ii) 1.85%. After the Reinvestment Period, the applicable spread is 3.00% per year. There is also a non-usage fee of (i) 0.40% per year for the first six months following the Closing Date (the "Ramp-Up Period"), and (ii) 0.50% per year thereafter, in each case, on the unused portion of the Citibank Facility, payable quarterly; provided that if after the Ramp-Up Period the unused portion of the Citibank Facility is greater than 30% of the commitments under the Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the Citibank Facility.

The Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets.

54

As part of the Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including, but not limited to, restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the Citibank Facility.

Under the Citibank Facility, we and OSI 2 SPV, as applicable, have made customary representations and warranties, and are required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities.

OSI 2 SPV’s borrowings are non-recourse to us but are considered borrowings of us for purposes of complying with the asset coverage requirements under the Investment Company Act.

As of March 31, 2020 and September 30, 2019, we had $95.0 million and $18.0 million outstanding under the Citibank Facility, respectively. Our borrowings under the Citibank Facility bore interest at a weighted average interest rate of 3.57% for the six months ended March 31, 2020. For the three and six months ended March 31, 2020, we recorded interest expense (inclusive of fees) of $818,689 and $1,383,309, respectively, related to the Citibank Facility.

Contractual Obligations

	Payments due by period as of March 31, 2020
	Total		< 1 year		1-3 years		3-5 years		> 5 years
CNB Facility	$	55,000,000	$	55,000,000	$	—	$	—	$	—
Interest due on CNB Facility	886,009		886,009		—		—		—
Citibank Facility	95,000,000		—		—		95,000,000		—
Interest due on Citibank Facility	13,555,560		3,135,475		6,270,950		4,149,135		—
Total	$	164,441,569	$	59,021,484	$	6,270,950	$	99,149,135	$	—

Off-Balance Sheet Arrangements

We may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As indicated in the table below, as of March 31, 2020 and September 30, 2019, off-balance sheet arrangements consisted of $19,261,420 and $11,030,903, respectively, of unfunded commitments to provide debt financing to certain of our portfolio companies. Such commitments are subject to the portfolio company's satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in our Consolidated Statements of Assets and Liabilities.

	March 31, 2020		September 30, 2019
WPEngine, Inc.	$	9,504,950	$	—
Assembled Brands Capital LLC	3,586,452		3,807,021
Corrona, LLC	1,560,000		—
MRI Software LLC	1,035,963		—
PaySimple, Inc.	876,659		2,695,000
Accupac, Inc.	856,511		—
OEConnection LLC	822,511		817,204
Acquia Inc.	468,601		—
Apptio, Inc.	461,538		461,538
iCIMs, Inc.	88,235		88,235
Sorrento Therapeutics, Inc.	—		2,400,000
Mindbody, Inc.	—		761,905
	$	19,261,420	$	11,030,903

Regulated Investment Company Status and Distributions

We anticipate that we will make quarterly distributions of at least 90% of our realized net ordinary income and net short-term capital gains in excess of our net long-term capital losses, if any, then available for distribution, each as determined by our board of

55

directors in accordance with applicable law and the terms of the Governing Documents. Any distributions will be declared out of assets legally available for distribution. We expect quarterly distributions to be paid from income primarily generated by interest earned on our investments, although distributions to stockholders may also include a return of capital.

We have elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code. To maintain RIC qualification, we must distribute to our stockholders, for each tax year, at least 90% of our “investment company taxable income” for that year. In order to avoid certain excise taxes imposed on RICs, we intend to distribute during each calendar year an amount at least equal to the sum of: (1) 98% of our ordinary income for the calendar year; (2) 98.2% of our capital gain net income (both long-term and short-term) for the one-year period ending on October 31 of the calendar year; and, (3) any undistributed ordinary income and capital gain net income for preceding years on which we paid no U.S. federal income tax less certain over-distributions in prior years. In addition, although we currently intend to distribute realized net capital gains (i.e., net long term capital gains in excess of short term capital losses), if any, at least annually, we may in the future decide to retain such capital gains for investment, pay U.S. federal income tax on such amounts at regular corporate tax rates, and elect to treat such gains as deemed distributions to stockholders. We can offer no assurance that we will achieve results that will permit the payment of any cash distributions and, to the extent that we issue senior securities, we will be prohibited from making distributions if doing so causes us to fail to maintain the asset coverage ratios stipulated by the Investment Company Act or if distributions are limited by the terms of any of our borrowings.

Depending on the level of taxable income and net capital gain earned in a year, we may choose to carry forward taxable income or net capital gain for distribution in the following year and pay the applicable U.S. federal excise tax. Distributions will be appropriately adjusted for any taxes payable by us or any direct or indirect subsidiary through which it invests (including any corporate, state, local, non-U.S. and withholding taxes). Any Incentive Fee to be paid to our Adviser will not be reduced to take into account any such taxes.

We may generate qualified net interest income or qualified net short-term capital gains that may be exempt from U.S. withholding tax when distributed to foreign stockholders. A RIC is permitted to designate distributions of qualified net interest income and qualified short-term capital gains as exempt from U.S. withholding tax when paid to non-U.S. shareholders with proper documentation. The following table, which may be subject to change as we finalize our annual tax filings, lists the percentage of qualified net interest income and qualified short-term capital gains for the year ended September 30, 2019, our most recently completed tax year end.

Year Ended	Qualified Net Interest Income		Qualified Short-Term Capital Gains
September 30, 2019	96.0	%	—

The following table reflects the distributions per share that we have paid on our common stock during the six months ended March 31, 2020:

Record Date	Payment Date	Amount per Share		Cash Distribution
November 7, 2019	November 21, 2019	$	0.29	$	2,409,859
December 13, 2019	December 30, 2019	0.32		2,659,155
March 13, 2020	March 31, 2020	0.31		2,576,058
		$	0.92	$	7,645,072

No distributions were paid to our stockholders during the six months ended March 31, 2019.

Related Party Transactions

We have entered into the Investment Advisory Agreement with the Adviser and the Administration Agreement with the Administrator, a wholly-owned subsidiary of the Adviser. The Adviser is a registered investment adviser under the Investment Advisers Act of 1940, as amended, that is partially and indirectly owned by Oaktree Capital Group, LLC.

Recent Developments

Distribution Declaration

On May 11, 2020, our board of directors approved a quarterly distribution not to exceed $3.4 million, which is payable in cash on June 30, 2020 to our stockholders of record as of the close of business on June 15, 2020.

56

Capital Drawdown

On April 30, 2020, we issued 5,832,194 shares of Common Stock for an aggregate offering price of approximately $101.3 million pursuant to the Subscription Agreement and a capital drawdown notice delivered by us to our investors dated April 20, 2020.

Investment Advisory Agreement

On May 11, 2020, the Adviser effected the novation of the Investment Advisory Agreement to Oaktree Fund Advisors, LLC, a registered investment adviser under common control with the Adviser.  Immediately following such novation, we and Oaktree Fund Advisors, LLC entered into a new investment advisory agreement with the same terms, including fee structure, as the Investment Advisory Agreement.

57

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are subject to financial market risks, including changes in the valuations of our investment portfolio and interest rates.

Valuation Risk

Our investments often do not have a readily available market price, and we value these investments at fair value as determined in good faith by our board of directors, with the assistance of the Audit Committee and the Adviser. There is no single standard for determining fair value in good faith and valuation methodologies involve a significant degree of management judgment. In addition, our valuation methodology utilizes discount rates in part in valuing our investments, and changes in those discount rates may have an impact on the valuation of our investments. Accordingly, valuations by us do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments. Estimated fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to our consolidated financial statements.

Interest Rate Risk

We are subject to financial market risks, including changes in interest rates. Changes in interest rates may affect both our cost of funding and our interest income from portfolio investments, cash and cash equivalents and idle funds investments. Our risk management systems and procedures are designed to identify and analyze our risk, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs. Our investment income will be affected by changes in various interest rates, including LIBOR and prime rates, to the extent our debt investments include floating interest rates.

As of March 31, 2020, 94.9% of our debt investment portfolio at fair value bore interest at floating rates. The composition of our floating rate debt investments by interest rate floor as of March 31, 2020 and September 30, 2019 was as follows:

	March 31, 2020				September 30, 2019
($ in thousands)	Fair Value		% of Floating Rate Portfolio		Fair Value		% of Floating Rate Portfolio
0%	$	171,170,271	51.05	%	$	148,908,568	55.02	%
>0% and <1%	7,656,376		2.28		6,770,487		2.50
1%	152,922,368		45.60		110,905,192		40.98
>1%	3,578,269		1.07		4,068,900		1.50
Total	$	335,327,284	100.00	%	$	270,653,147	100.00	%

Based on our Consolidated Statements of Assets and Liabilities as of March 31, 2020, the following table shows the approximate annualized net increase (decrease) in net assets resulting from operations of hypothetical base rate changes in interest rates, assuming no changes in our investment and capital structure. However, there can be no assurances our portfolio companies will be able to meet their contractual obligations at any or all levels of increases in interest rates.

Basis point increase	Increase in Interest Income		(Increase) in Interest Expense			Net increase (decrease) in net assets resulting from operations
250	$	9,497,756	$	(3,750,000	)	$	5,747,756
200	7,582,113		(3,000,000		)	4,582,113
150	5,698,653		(2,250,000		)	3,448,653
100	3,783,011		(1,500,000		)	2,283,011
50	1,899,551		(750,000		)	1,149,551

58

Basis point decrease (1)	(Decrease) in Interest Income			Decrease in Interest Expense		Net increase (decrease) in net assets resulting from operations
50	$	(1,332,303	)	$	750,000	$	(582,303	)
100	(2,315,380		)	1,500,000		(815,380		)
150	(2,596,964		)	2,103,775		(493,189		)
200	(2,599,194		)	2,103,775		(495,419		)

 __________

(1) The effect of a greater than 200 basis point decrease is limited by interest rate floors on certain investments.

We regularly measure exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities. Based on this review, we determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates. The interest rate on the principal balance outstanding for all floating rate loans is indexed to the LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. The following table shows a comparison of the interest rate base for our outstanding debt investments, at principal, and our outstanding borrowings as of March 31, 2020 and September 30, 2019:

	March 31, 2020				September 30, 2019
	Debt Investments		Borrowings		Debt Investments		Borrowings
Prime rate	$	446,000	$	—	$	—	$	—
LIBOR:
30 day	207,731,645		55,000,000		177,185,974		65,000,000
60 day	—		—		—		—
90 day	133,330,511		95,000,000		92,053,874		18,000,000
180 day	35,364,881		—		1,409,167		—
EURIBOR:
30 day	3,037,188		—		2,725,500		—
Fixed rate	19,554,148		—		19,020,775		—
Total	$	399,464,373	$	150,000,000	$	292,395,290	$	83,000,000

59

Item 4. Controls and Procedures

As of the end of the period covered by this report, management, with the participation of the Company’s Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2020. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Based on the evaluation of our disclosure controls and procedures as of March 31, 2020, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, in timely identifying, recording, processing, summarizing and reporting any material information relating to us that is required to be disclosed in the reports we file or submit under the Exchange Act.

There were no changes in our internal control over financial reporting that occurred during the three months ended March 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.     Legal Proceedings

From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under loans to or other contracts with our portfolio companies. We are not currently subject to any material legal proceedings, and, to our knowledge, no material legal proceeding is threatened against us.

Item 1A. Risk Factors

In addition to the other information in this Form 10-Q, consideration should be given to the information disclosed in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended September 30, 2019 and the following risk factors we have added regarding the impacts of the COVID-19 pandemic, which reemphasize and in some cases update certain risk factors we have previously disclosed and provide specific context under the current environment.

Global economic, political and market conditions caused by the current public health crisis have adversely affected, and may continue to adversely affect our business, results of operations and financial condition and those of our portfolio companies.

A novel strain of coronavirus initially appeared in China in late 2019 and has rapidly spread to other countries, including the United States.  In an attempt to slow the spread of the coronavirus, governments in many jurisdictions, including the United States, the United Kingdom, France, Italy, South Korea and China, have placed restrictions on travel, issued “stay at home” orders and ordered the temporary closure of "non-essential" businesses, such as factories and retail stores.  As these restrictions and closures have impacted supply chains, consumer demand and the operations of many business, uncertainty surrounding the full economic impact of the coronavirus pandemic has contributed to significant market volatility and disruption. These and any other unfavorable economic conditions may have long-term effects on the U.S. and global financial markets and have caused (and may cause further) economic uncertainties and deterioration in the United States and worldwide.

Disruptions in the capital markets have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets, significant write-offs in the financial sector and re-pricing of credit risk in the broadly syndicated market.  These and any other unfavorable economic conditions created by the coronavirus and related restrictions and closures could increase our funding costs, limit our access to the capital markets and result in a decision by lenders not to extend credit to us. These events also could negatively impact the fair value of the investments that we hold, limit our investment originations (including as a result of the investment professionals of our Adviser diverting their time to the restructuring certain investments), negatively impact our operating results and limit our ability to grow.  In addition, our success

60

depends in substantial part on the management, skill and acumen of our Adviser, whose operations may be adversely impacted, including through quarantine measures and travel restrictions imposed on its investment professionals or service providers, or any related health issues of such investment professionals or service providers.

In addition, the coronavirus-related restrictions and closures and related market conditions have resulted in certain of our portfolio companies halting or significantly curtailing operations and have negatively affected the supply chains of certain of our portfolio companies.  The financial results of middle-market companies in which we primarily invest, have experienced deterioration, which could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration will further depress the outlook for middle-market companies. Further, adverse economic conditions may decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions may require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may continue to be, negatively impacted by these economic or other conditions, which may result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations.

As the potential impact of the coronavirus remains difficult to predict, the extent to which the coronavirus could negatively affect our and our portfolio companies’ operating results or the duration of any potential business or supply-chain disruption is uncertain. Any potential impact to our results of operations will depend to a large extent on future developments regarding the duration and severity of the coronavirus and the actions taken by governments and their citizens to contain the coronavirus, all of which are beyond our control. We monitor developments in economic, political and market conditions and seek to manage our investments in a manner consistent with achieving our investment objective, but there can be no assurance that we will be successful in doing so.

As a result of the COVID-19 pandemic and related government actions, certain of our portfolio companies are distressed, and we have opportunistically acquired the securities and obligations of distressed companies.  These and future investments in distressed or bankrupt companies are subject to significant risks, including lack of income, extraordinary expenses, uncertainty with respect to satisfaction of debt, lower-than-expected investment values or income potentials and resale restrictions.

As a result of the COVID-19 pandemic and related government actions, certain of our portfolio companies are distressed,

and we have opportunistically acquired the securities and obligations of distressed companies. At times, distressed debt obligations may not produce income and may require us to bear certain extraordinary expenses (including legal, accounting, valuation and transaction expenses) in order to protect and recover our investment. Therefore, when we invest in distressed debt, our ability to achieve current income for our stockholders may be diminished, particularly where the portfolio company has negative EBITDA.

We also are subject to significant uncertainty as to when, in what manner and for what value the distressed debt we acquire will eventually be satisfied whether through a refinancing, restructuring, liquidation, an exchange offer or plan of reorganization involving the distressed debt securities or a payment of some amount in satisfaction of the obligation. In addition, even if an exchange offer is made or plan of reorganization is adopted with respect to distressed debt held by us, there can be no assurance that the securities or other assets received by us in connection with such exchange offer or plan of reorganization will not have a lower value or income potential than may have been anticipated when the investment was made.

Moreover, any securities received by us upon completion of an exchange offer or plan of reorganization may be restricted as to resale. As a result of our participation in negotiations with respect to any exchange offer or plan of reorganization with respect to an issuer of distressed debt, we may be restricted from disposing of such securities.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4.     Mine Safety Disclosures

Not applicable.

61

Item 5. Other Information

None.

62

Item 6. Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

Exhibit	Description
10.1	Investment Advisory Agreement, dated as of May 11, 2020, by and between the Company and Oaktree Fund Advisors, LLC.*
31.1	Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.*
31.2	Certification of Chief Financial Officer (Principal Financial Officer) Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
32.1	Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2	Certification of Chief Financial Officer (Principal Financial Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

* Filed herewith.

63

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

OAKTREE STRATEGIC INCOME II, INC.
By:	/s/   Armen Panossian
	Armen Panossian
	Chairman, Chief Executive Officer and Chief Investment Officer
By:	/s/    Mel Carlisle
	Mel Carlisle
	Chief Financial Officer and Treasurer

Date: May 12, 2020

64